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Genetics of Equine Insect Bite Hypersensitivity and Genetic 
Diversity in Horses 
Abstract 
Genetic variation contributing to the phenotypic variation was utilized in this thesis to 
understand the genetic background of a complex trait IBH, and to understand genetic 
diversity and relationships between various horse populations.  
IBH is the most common skin allergic disorder in horses, caused by bites of midges, 
predominantly Culicoides species. It affects various horse breeds worldwide. With no 
effective treatment, IBH degrades horse health and causes economic loss. In this thesis, 
we used genome-wide SNPs to identify regions contributing to genetic variance of IBH 
susceptibility. We also investigated influence of increased number of horses and dense 
SNPs on identification of genomic regions associated to IBH susceptibility. Multiple 
genomic regions with small effects were observed in Studies I-III. Interesting genomic 
regions in the Icelandic horse population across the studies I and II, was observed on 
chromosomes 1, 7, 10, 15 and 17. The percentage of the genetic variance explained by 
top ten windows increased from 3.07% (Study I) to 6.56% (Study II). Novel genomic 
regions were identified when number of Icelandic horses was increased in Study II. 
Using dense SNPs on the Exmoor pony population we identified novel genomic 
regions, on chr 8, associated to IBH susceptibility, though with borderline significance.  
In Study IV, pre-conceived understanding about evolutionary history of horse 
populations matched obtained results from investigation of genetic relationships within 
Dutch warmblood populations (pairwise mean FST ≤ 0.070), and within pony-like 
populations (pairwise mean FST ≤ 0.078). Horse populations with similar genetic 
background might share similar genetic components for IBH susceptibility. The 
Friesian horse population had lowest diversity (mean inbreeding coefficients: fi: 30.4%, 
fiROH= 22.2%) in Study IV and was genetically distinct (FST ranged from 0.13 to 0.17). 
This might be a result of a history of several population bottlenecks and selection on a 
closed breeding scheme. Low diversity in immunity related genes, observed in the 
Friesian horse population, might have led to increased prevalence of IBH. Similarly, 
low susceptibility of IBH in a warmblood population, KWPN sport horse population 
might be due to high genetic diversity ( if  =-6.9%). High genetic diversity in KWPN 
sport horse population might be a result of an open breeding scheme and interbreeding 
with other warmblood populations. 
 
Keywords: horse, genome-wide association study, insect bite hypersensitivity, 
Culicoides, case-control design, genetic diversity, inbreeding, genetic relationships, 
homozygosity, signatures of selection 
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1 Introduction 
1.1 Genetic variation 
Mankind has improved phenotypes of animals and plants via artificial selection 
and breeding. In the past selection was performed taking into account only 
visible traits for example coat color in horses, patterns in flowers etc. or traits 
that can be measured such as volume of milk produced by a cow, body weight 
of chicken, performance in horses etc. This variation in phenotype (P) is a sum 
of both genetic factors (G) and environmental factors (E). For example, a large 
production of milk by a cow depends on the cow’s own genes and the 
environment of the cow such as quality of feed provided to the cow. A 
contribution of both G and E is observed in complex traits like the skin allergic 
disorder studied in this thesis, insect bite hypersensitivity (IBH) in horses. 
The genetic component influencing a phenotype of an individual could be 
due to a single gene (monogenic) or multiple genes (polygenic). A complex 
trait is influenced by multiple genes and environment. A complex trait is 
usually modelled as a product of multiple genes, each with small effects. It 
could also be that it is a result of multiple genes with a few genes having major 
effect on the phenotype. An additional source of genetic variation affecting 
complex traits is caused by interaction of multiple genes (epistasis) present at 
different loci in the genome. The proportion of phenotypic variance caused by 
genetic variation is known as heritability (Goddard & Hayes, 2009). In the 
field of animal breeding and genetics, the narrow sense heritability (h2) is 
much of interest. h2 refers to the proportion of phenotypic variation caused by 
additive genetic variation (Goddard & Hayes, 2009). The additive genetic 
variation can most effectively be selected on. The additive genetic variance is 
usually denoted as 𝜎𝐴
2, and is the variance of the breeding values of the 
individuals in the population. 
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Breeding denotes programs, and procedures aimed at modifying phenotypes 
in populations to improve production or performance and reduce prevalence of 
diseases. Breeding programs rely on selection of the best individuals to 
produce the next generation. Traditionally, the breeding values were estimated 
from records of own and relatives’ phenotypes, pedigree information and the 
heritability concept of phenotypes. Information on traits of interest from 
progenies, parents and other relatives will increase the accuracy of estimated 
breeding values (EBVs). Selection of an individual as a breeding animal by 
estimating EBVs does not require understanding of the biological mechanisms 
behind the trait of interest. However, this traditional method of estimating 
breeding values is not suitable for all kinds of traits. For a trait such as IBH in 
horses, with low heritability and a smaller number of progeny per stallion, the 
EBVs have low accuracy. 
Nowadays with arrival of molecular technologies, genetic variation is 
utilized by using different forms of genetic evaluations. Through the concept of 
genomic selection, breeding values can be estimated based on genome-wide 
genetic variants without prior knowledge of their influence on the traits. 
Advancements in molecular technologies have also given us opportunity to 
understand the biological mechanisms behind the traits. By associating genetic 
variants with a trait of interest, genomic regions and subsequently genes 
influencing the outcome of the trait can be identified. The knowledge of genes 
influencing a trait can be utilized to select individuals in order to change the 
trait of interest. 
Genetic variation has also been successfully utilized to understand the 
evolutionary history of populations by studying the population genetic 
structure, linkage and recombination rates. In case of domestic animals; 
selection and breeding has played an important role in shaping their genome. 
Knowledge regarding genetic diversity of populations and relationships 
between various populations was traditionally estimated using pedigree 
information and now by using genetic variants. 
Estimation of the extent of genetic variation in the populations has been 
based on identification of genetic variants in visible traits (color, shape, pattern 
or other morphological aspects) and measurements of performance traits, 
allozymes (enzymes and proteins), nucleotide and amino acid sequences, and 
mutants (Hedrick, 2011). 
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1.2 Genetic variants 
Different forms of the genetic variants at nucleotide sequence level have been 
identified in the genome such as restriction fragment length polymorphisms 
(RFLPs), microsatellites, single nucleotide polymorphisms (SNPs). The 
genetic variants such as structural variants (copy number variants: insertion, 
deletion, duplications) change quantity of a sequence. Other types of genetic 
variants do not necessarily change the quantity of a sequence, for example: 
inversions and translocations. RFLPs were the first genetic variants to be 
developed and were used to map disease in humans (Gusella et al. 1983). Then 
microsatellites were developed. Microsatellites are short stretches of 
oligonucleotides repeats of variable lengths. In a population, a microsatellite 
locus can have many alleles. But microsatellites are present in lower density in 
the genome than SNPs.  
1.2.1 Single nucleotide polymorphism  
The most common form of genetic variant investigated is SNP. A SNP is a 
specific locus in the genome where a single nucleotide (base pairs) differs 
between individuals in a population. SNPs have low polymorphic 
(predominantly bi-allelic) nature but it is compensated by their abundance in 
the genome, ease of genotyping or automation (Kruglyak, 1997) and low 
mutation rates. In principle, a SNP can contain any of the four nucleotides. The 
mutation rate is estimated at 10-8 changes per nucleotide per generation (Li et 
al., 1996). It corresponds to ~100 new SNPs per individual (Kondrashov, 
1995). Hence, the chance of a second independent mutation (introducing a 
different nucleotide) occurring in the same locus is very low.   
Previously, a horse could be genotyped for around 50,000 SNPs using a 
commercial genotyping array. A horse can now be commercially genotyped for 
around 670,000 SNPs. Similarly; in other species such as cattle recent 
commercial genotyping array contains around 777,000 SNPs. In humans, 
larger number of SNPs is used compared to domestic animals.  
The SNPs have been used in different fields such as marker-assisted 
selection, genomic selection, mapping of quantitative trait loci, and genome-
wide association (GWA) studies. We can also utilize SNPs to study 
evolutionary history by investigating allele frequency, length of homozygosity, 
patterns and distribution of homozygosity. 
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1.3 Methods to estimate genetic variation 
Estimation of genetic variation includes prediction of outcome of the genotype-
phenotype relationships (Goddard & Hayes, 2009). The estimation of genetic 
variation also includes discovering or mapping of genes and pathways for 
humans and domesticated animals (Goddard & Hayes, 2009). The traditional 
methods for mapping genes and pathways used linkage analysis, a family-
based method to search for the chromosomal location associated with a trait 
locus by demonstrating co-segregation of the disease, or another trait, with 
genetic markers of known chromosomal location (Ott et al., 2011). Linkage 
analysis has been successful for mapping Mendelian traits in humans such as 
Huntington’s disease (Gusella et al., 1983), and cystic fibrosis (Tsui et al., 
1985). It has also been successfully used to identify genes regarding 
susceptibility to the diseases like breast cancer (Walsh & King, 2007) and 
diabetes (Julier et al., 1991), and also traits in domestic animals such as milk 
production (Georges et al., 1995). In the past, it was suggested that linkage 
analysis had a limited power to detect weak effects of genes in complex human 
diseases (Risch & Merikangas, 1996) and thus linkage disequilibrium (LD) 
association mapping abbreviated to “association mapping”, was used. LD 
between two polymorphic loci can be quantified by measuring the correlation 
of allele frequencies at the loci.  
1.3.1 Genome-wide association study 
Association studies are mainly carried out on a genome-wide basis, referred to 
as genome-wide association (GWA) studies. GWA studies do not require 
previous knowledge about the trait under investigation unlike candidate gene 
studies. GWA studies have the capacity to identify novel loci influencing the 
trait of interest. In GWA studies genetic variation is assayed in the entire 
genome by relating genotypes of large number of genetic variants, typically 
SNPs, to phenotypes without prior hypothesis about trait mechanisms 
(Bonnelykke et al., 2015; Ball, 2013). The idea behind GWA studies is 
described in Figure 1. GWA studies are designed to detect associations with 
causal variants (causal variants in LD with SNPs) that are relatively common 
in the population. The SNPs in the genotyping arrays are chosen to be common 
(with minor allele frequency higher than 5%). GWA studies assume common 
causal variants for disease. Hence, the SNPs linked to the genomic regions 
with stronger effects on the expression of disease can be identified in GWA 
studies (Stock et al., 2016).  
The genomic regions identified through GWA studies can help to 
understand the biological mechanisms underlying the trait of interest, and can 
improve genomic prediction models. If the identified genomic regions are 
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supported by identification of causal variants, then it can enable marker-based 
test or direct gene tests.  
In humans, GWA studies have contributed in identification of different 
pathways in autoimmune diseases as reviewed by Visscher et al. (2012), 
identification of multiple susceptibility loci for breast cancer as reviewed by 
Skol et al. (2016) to mention some examples. In livestock and companion 
animals, GWA studies have identified multiple genomic regions for health and 
disease related traits (Bermingham et al., 2014; Karlsson et al., 2013), fertility 
related traits (Nayeri et al., 2016; Schneider et al., 2015; Hoglund et al., 2014), 
production traits (Nayeri et al., 2016; Wolc et al., 2012) among other 
examples. GWA studies have also led to discovery of causative mutations for 
several traits in dogs and cattle as reviewed in Goddard and Hayes (2009). 
Similarly, in horses, GWA studies have identified genomic regions for various 
traits and diseases such as body size, diseases such as equine uveitis, 
osteochondritis dissecans, performance traits (jumping ability) (as reviewed in 
(Stock et al., 2016; Finno & Bannasch, 2014)). Identification of SNPs followed 
by sequencing identified causal mutations in the genes associated with 
gaitedness (Andersson et al., 2012a), diseases such as Lavender foal syndrome 
(Brooks et al., 2010), and Foal immunodeficiency syndrome (Fox-Clipsham et 
al., 2011).  
In this thesis, GWA studies were performed to increase our understanding 
about a skin allergic disorder in horses, equine insect bite hypersensitivity 
(IBH). Before moving towards IBH, the general idea regarding pathogenesis of 
allergy, allergens, allergy in humans and horses will be presented below. This 
will be followed by a short introduction to IBH in horses.  
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1.3.2 Allergy 
1.3.2.1 Hypersensitivity reactions 
Exposure to harmless antigens (allergens) can lead to abnormal immune 
responses, both innate and adaptive, in susceptible individuals. These allergens 
manifest signs and symptoms of over reactivity or ‘hypersensitivity reactions’. 
The hypersensitivity reactions are categorized based on different immune 
mediators and duration taken to observe symptoms due to reactions. Allergic 
disorders are IgE mediated hypersensitivity reactions. A type I hypersensitivity 
reaction is mediated by Immunoglobulin E (IgE) (Galli et al. 2008). An IgE 
mediated hypersensitive reaction can occur within minutes of allergen 
exposure (type I).  The IgE mediated hypersensitive reactions can also occur 
after 2 to 4 hours and peaks 6 to 9 hours after allergen exposure. Such IgE 
Figure 1. Orange and blue arrows represent SNPs. The orange SNP influences our trait of 
interest. A) Orange SNP is genotyped. Association analysis will identify orange SNP leading to 
direct association. B) Only blue SNPs are genotyped. Association analysis will not identify causal 
SNP but will identify blue SNP depending on LD between each blue SNPs and orange SNP. C) 
SNP1 and SNP2 are genotyped for eight observations. Only SNP1 will be associated with trait of 
interest as it is in LD (0.03) with causal SNP. The concept for this figure has been derived from 
Hirschhorn and Daly (2005) and Jungerius (2004). 
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mediated hypersensitivity reactions are known as type IV hypersensitivity 
reactions (Klug et al., 2009). Allergic reactions in humans include allergic 
asthma, allergic rhinitis (hay fever), eczema and food allergies.  
1.3.2.2 Pathogenesis of allergy 
When an individual is exposed to an allergen, depending on the susceptibility 
of an individual, either a healthy or an allergic immune response towards the 
allergen occurs (Traidl-Hoffmann et al., 2009). The susceptibility of an 
individual depends in part on the genetics of an individual.  
After exposure, allergen epitopes are presented to allergen-specific helper T 
cells (Th0) by Major histocompatibility (MHC) class II molecules on the 
surface of antigen presenting cells (APC). In IBH, immature dendritic cells 
present allergens to Th0 cells (Meulenbroeks, 2015b). In susceptible 
individuals, Th0 cells develop into effector T cells known as type 2 helper T 
cells (Th2). A Th2 immune response leads to the development of B cells that 
will produce IgE (IgE switched B cells). The IgE switched B cells transform to 
IgE producing plasma cells and produce allergen-specific IgE. The allergen-
specific IgE binds to effector cells like mast cells and basophils. This binding 
after exposure to the allergen, results in cellular activation and release of 
inflammatory mediators (histamines, leukotrienes and cytokines) responsible 
for the symptoms of allergic disorders. 
1.3.2.3 Allergens 
Allergens like food, plant pollen, drugs, insect products, mold, animal hair, 
latex and others can give rise to different allergic reactions. The route of 
exposure, dose and function of the allergens is important for allergenicity 
(Traidl-Hoffman et al. 2009). Allergens that elicit type I hypersensitivity 
reactions are usually described as harmless environmental substances. Most of 
the allergens are proteins and glycoproteins (Traidl-Hoffmann et al., 2009). 
However, some of the allergens do have biological activities influencing their 
allergenicity for example a major allergen of house dust mite, Der p I. Der p I 
causes allergic reactions like eczema, asthma and rhinitis. The allergen 
regulates IgE production (Hewitt et al., 1995) and has also been shown to bias 
the immune response in favour of Th2 with the proteolytic activity 
(Ghaemmaghami et al., 2002). 
1.3.2.4 Allergy in humans 
Allergic disorders are a common problem in humans and animals. The 
symptoms caused by allergies can range from mild discomfort to fatal 
anaphylactic shock. Roughly 25% of people in the developed world suffer 
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from allergic disorders (Galli et al., 2008). Moreover, the prevalence of allergic 
disorders is increasing in the industrialized countries.  
Allergic disorders are complex as many genes and environmental factors 
influence development of allergic disorders. In humans, high genetic 
predisposition regarding various allergic disorders has been suggested. 
Estimated heritability of asthma and hay fever in 3,808 pairs of Australian 
twins population ranged from 60 to 70% (Duffy et al., 1990). The heritability 
estimates of childhood asthma, hay fever, eczema and food allergies in 25,306 
Swedish twins ranged from 60 to 82% (Ullemar et al., 2016).  
The polygenic nature of allergic disorders has been confirmed in several 
studies. For example three candidate genes: IL1R1, IL18R1 and ILR18RAP 
were significantly associated with susceptibility of allergic asthma in a family-
based association study in humans (Reijmerink et al., 2008). Similarly, in a 
GWA study of atopic dermatitis (AD) in children, a locus on EDC gene (chr 
1), five loci spanning between RAD50 locus to IL13 locus (chr 5), seven loci 
on MHC region (chr 6), and two loci close to LRRC32 gene (chr 11) showed 
significant association (Weidinger et al., 2013). Odds ratios of AD for the 
associated loci ranged between 0.64 and 1.68. 
Atopic dermatitis in humans and IBH in horses have similar features 
(Schaffartzik et al., 2012). Polygenic influence in development of IBH in 
horses has been observed in our study along with other studies. Along with 
polygenic nature, development of allergic disorders is influenced by several 
environmental factors. In humans, a reduced risk of allergic disorders was 
observed with exposure to environmental factors such as farm animal and 
products (Douwes et al., 2008), and to the domestic dogs (Thorsteinsdottir et 
al., 2016). Also a higher intake of a diet rich in antioxidants (Devereux & 
Seaton, 2005) and higher number of siblings (Kinra et al., 2006) reduced the 
risk of allergic disorders. Gender also seemed to influence the risk of allergic 
disorder (Uekert et al., 2006) where boys showed high susceptibility to allergy. 
1.3.2.5 Allergy and Major histocompatibility complex 
Major histocompatibility complex (MHC) is a general term used for the 
genomic region encoding MHC molecules. In humans, the MHC region is 
denoted as Human leukocyte antigen (HLA) and located on the short arm of 
chromosome (chr) 6 while in the horse, MHC region is located on chr 20. The 
MHC region contains three classes of genes: class I, class II and class III 
genes. The arrangement of three regions in the horse genome can be viewed in 
Figure 2. The MHC region contains genes encoding MHC molecules and other 
genes related with immunity. MHC class I genes encodes glycoproteins 
expressed on the surface of nearly all nucleated cells (Owen et al., 2009). 
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MHC class I molecules bind peptides and present them to cytotoxic (CD8+) T 
cells to initiate immune response. MHC class II molecules encodes 
glycoproteins expressed predominantly on antigen presenting cells (APCs) 
such as macrophages, dendritic cells and B cells (Owen et al., 2009). The 
MHC class II glycoproteins present antigens to the helper (CD4+) T cells and 
initiate immune response. The MHC class II region spans more than one mega 
bases (mb) and harbours two Eqca-DQA loci (DQA1 and DQA2), two Eqca-
DQB loci (DQB1 and DQB2), three Eqca-DRB loci (DRB1, DRB2 and DRB3), 
and one Eqca-DRA locus which is polymorphic in horses (Gustafson et al., 
2003). The map and annotation of MHC class II region is still on progress. For 
example, three loci has been reported for Eqca-DQB gene in MHC class II 
region (Immuno Polymorphism Database).  
In humans, HLA region has been associated with allergic disorders as 
reviewed in Tamari et al. (2013). In horses, the MHC region has been 
associated with allergic disorders such as recurrent airway obstruction (RAO) 
susceptibility (Curik et al., 2003) and IBH susceptibility. IBH susceptibility 
has been associated to MHC class II region in different serological and 
candidate gene studies (Klumplerova et al., 2013; Andersson et al., 2012b; 
Marti et al., 1992). A same microsatellite marker was significantly associated 
with IBH susceptibility in Swedish-born Icelandic horses and Exmoor ponies 
(Andersson et al., 2012b). Also, Eqca-DRB3 gene in MHC class II region was 
associated with IBH susceptibility in Swedish-born Icelandic horses 
(Andersson et al., 2012b). Similarly, Eqca-DRA gene in MHC class II region 
showed significant association with IBH in Icelandic horses in Switzerland that 
were imported from Iceland (Klumplerova et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2. Position of MHC class I, II and III regions in horse genome. MHC class II region spans 
around 1mega bases (tentative position: 32.698 Mb – 33.729 Mb). This figure is an illustration 
from the study by Klumplerova et al. (2013). 
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1.3.2.6 Allergy in horses 
In horses, allergic disorders such as insect bite hypersensitivity (IBH), 
recurrent airway obstruction (RAO) or heaves, allergic rhino-conjunctivitis and 
recurrent utricaria or hives are IgE mediated hypersensitivity reactions (Fadok, 
2013).  RAO and IBH are commonly occurring allergic disorders in horses. 
These are the most studied allergic disorders in horses.  
RAO, or heaves, is a hypersensitivity reaction to inhaled stable dust, 
including mold spores (Swinburne et al., 2009). It is one of the most common 
disorders of the lower respiratory tract of mature horses and is influenced by 
multiple genes. Two loci on chr 13 and chr 15 have been associated with RAO 
susceptibility in Warmblood horses (Swinburne et al., 2009). Another gene 
TSLP was associated with development of RAO in horses (Klukowska-Rotzler 
et al., 2012). mRNA expressions of TSLP cytokine in clinical RAO cases were 
significantly higher (p < 0.05) than clinical RAO controls. The mRNA 
expression of TSLP cytokine also increased significantly after 30-day exposure 
to moldy hay in experimental RAO cases compared to no exposure to moldy 
hay. While significant increase in mRNA expression of TSLP was not observed 
for experimental RAO controls. TSLP cytokine produced by damaged 
epithelial cells induce Th2 immune response leading to hypersensitive reactions 
(Fadok, 2013). TSLP gene has also been significantly associated with IBH 
susceptibility in Icelandic horses (Klumplerova et al., 2013). Hence, some 
common genetic components might be shared between IBH and RAO 
manifesting allergic immune response.   
1.3.2.7 Insect Bite Hypersensitivity 
Background: 
IBH is a skin allergic reaction in horses. Such skin allergic disorders have been 
observed in many different horse breeds and in other species for instance 
sheep, cattle, donkey (Correa et al., 2007; Yeruham et al., 1993), dogs 
(Pucheu-Haston, 2016; Chamberlain, 1978) and hippopotamus (Spriggs & 
Reeder, 2012). IBH is known by different names in different parts of the world: 
“Queensland itch” in Australia, “Kasen disease” in Japan, “Sweet itch” in 
Great Britain, “Sommareksem” in Nordic countries, and the similar 
“Sommerekzem” in Germany (Schaffartzik et al., 2012; Brostrom et al., 1987). 
IBH is caused by bites of female midges of Culicoides species, and 
potentially also female black flies of Simulium species (Hellberg et al., 2009; 
Schaffartzik et al., 2009). It is a reaction towards allergens present in the saliva 
of these biting midges. IBH has been described as a type I hypersensitivity 
reaction with release of histamine and other inflammatory mediators from 
basophils and mast cells (Jonsdottir et al., 2015). However the involvement of 
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a type IV hypersensitivity reaction has also been suggested (Jonsdottir et al., 
2015; Schaffartzik et al., 2012).  
After exposure to the allergens some horses show symptoms of itchiness 
and scratch to get relief from itch. That leads to clinical symptoms such as 
scratches on the skin surface, hair loss, lesions, and possibly secondary 
infections. The clinical symptoms appear mainly around mane and tail, but also 
in other areas of body (Peeters et al., 2014; Eriksson et al., 2008). Most horses 
typically show clinical symptoms around spring and summer (Schurink et al., 
2013a) when Culicoides species are active. The symptoms disappear during 
autumn. Such occurrence of the clinical symptoms in a particular season is one 
of the characteristics that facilitate diagnosis of IBH. In severe cases, clinical 
symptoms persist. The horses develop clinical symptoms at various age, 
however average age of onset is observed to be 2 – 4 years (Schurink, 2012).  
The worldwide prevalence of IBH in different horse populations ranges 
from 3% in Great Britain to 60% in Australia as reviewed in Schaffartzik et al. 
(2012). Culicoides species have not been observed in Iceland. Icelandic horses 
exported from Iceland to the European continent had IBH prevalence of more 
than 50% as reviewed in Schaffartzik et al. (2012). The estimated prevalence 
of IBH in Swedish-born Icelandic horses ranged from 6.7% (441 horses used, 
(Brostrom et al., 1987)) to 8% (1,250 horses used, (Eriksson et al., 2008)). 
Knowledge regarding IBH prevalence in Exmoor pony population is limited. 
However, IBH has been observed as a significant problem in this pony 
population (Andersson et al., 2012b; ExmoorPonySociety).  
Some horses are genetically predisposed to get IBH susceptibility. Multiple 
genes seem to influence the genetic predisposition. Heritability of IBH on the 
continuous scale was estimated in Dutch Friesian breeding mares (0.16, SE = 
0.06) (Schurink et al., 2011), Dutch Shetland breeding mares (0.24, SE = 0.06) 
(Schurink et al., 2009), Swedish-born Icelandic horses (0.30, SE < 0.20) 
(Eriksson et al., 2008), and Belgian warmblood horses (0.65 for clinical status) 
(Peeters et al., 2015).  
Environmental factors play essential role in development of IBH. It is 
important to investigate an effect of the environmental factors while estimating 
true genetic component influencing IBH susceptibility in horses. The 
environmental factors related to exposure to allergens like region of habitat of 
horses (exposure to allergens) (Eriksson et al., 2008; Brostrom et al., 1987), 
time period of collection of data (Schurink et al., 2013b), protective rugs 
(Olsen et al., 2011) have been observed to influence IBH prevalence. The 
environmental factors related to mares such as age, coat colour, wither height, 
body condition (amount of fat stored in the body) (Peeters et al., 2014; 
Schurink et al., 2013b) had significant effect on IBH prevalence. The effect of 
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sex in development of IBH susceptibility is inconclusive (Peeters et al., 2011; 
Eriksson et al., 2008; Brostrom et al., 1987).  
Diagnosis: 
Diagnosis of IBH is performed by observing the clinical symptoms and 
examining the medical history of horses. The diagnosis is also performed using 
different in-vivo and in-vitro diagnostic tests such as intradermal tests (IDT) 
(Langner et al., 2008; Fadok & Greiner, 1990), allergen-specific IgE and IgG 
enzyme-linked immunosorbent assay (ELISA) (Meide et al., 2014; van der 
Meide et al., 2014; Langner et al., 2008), basophil degranulation test/histamine 
release test (HRT) (Langner et al., 2008) and the cellular antigen stimulation 
tests/ sulfidoleukotriene test (Klumplerova et al., 2013; Marti et al., 1999). The 
diagnostic tests helps to identify sensitized horses (horses that show IgE 
reactivity but without clinical symptoms) from unsensitized horses. Observing 
presence of the clinical symptoms along with medical history of the horses is 
considered as a gold standard method for diagnosing IBH. However, it is 
suggested to supplement this method by other in-vitro or in-vivo diagnostic 
methods.  
Prevention and Treatment: 
IBH causes extreme discomfort; decrease quality of life for horses, and results 
in poor horse welfare. Horses are used for various purposes like sports, 
recreation, agriculture etc. Horses suffering from IBH are unfit for riding, and 
have a reduced value (horse’s commercial value on average ranges from €1700 
to €10,000) (Horsegene) in the market creating economic loss for the horse 
owner. In some cases, horses suffering from IBH are euthanized.  
The best method to reduce IBH prevalence is to avoid an exposure to the 
biting midges totally. Total avoidance of exposure might not be possible, 
however exposure can be decreased by use of blankets on horses, overnight 
stabling (avoiding the time when the biting midges are active for example 
sunrise and sunset) (Olsen et al., 2011). Other methods include relocating 
horses to low-risk areas and use of insect repellents as reviewed in Schaffartzik 
et al. (2012). 
Research regarding genetics of IBH: 
With various researches we are able to understand that IBH susceptibility is 
indeed a complex disorder where both environmental and genetic factors 
influence its development. Environmental factors have been identified in 
various horse populations (Peeters et al., 2014; Schurink et al., 2013b; 
Eriksson et al., 2008). The genetic component influencing the susceptibility 
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has also been estimated. Further, immunity related genes located at MHC 
region and other regions have also been associated with IBH susceptibility in 
various candidate gene studies (Klumplerova et al., 2013; Vychodilova et al., 
2013; Andersson et al., 2012b). In candidate gene studies, the genes to be 
studies are included based on the previous knowledge of association of IBH 
like trait in other species for example humans. GWA studies (Schurink et al., 
2013a; Schurink et al., 2012) have been performed in different breeds to 
identify and quantify the genomic regions associated with IBH susceptibility. 
However, GWA studies are limited.  
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2 Aims of the thesis 
The overall aims of this thesis were to utilize genetic variation in horse 
populations to understand the genetics behind IBH in order to be able to reduce 
its prevalence, and to understand the evolutionary history, diversity, and 
genetic differences between various horse populations.  
Studies I-III investigated if any genome-wide genetic variants in an 
Icelandic horse population and an Exmoor pony population were associated 
with IBH. Identifying genetic variants can subsequently lead to identifying 
causal genes that influence IBH susceptibility in the studied horse populations.  
If causal genes can be identified and biological pathways behind IBH 
development are better understood, this could be used to develop therapeutic 
measures to reduce the prevalence of IBH. The identified genetic variants can 
also be used to formulate genetic tests to predict the risk of IBH susceptibility 
of an individual horse. The horses with a higher risk of IBH susceptibility 
could be removed from breeding to reduce the prevalence of IBH. 
Study IV investigated inbreeding level, distribution and patterns of runs of 
homozygosity segments, and differences between various horse populations 
utilizing the genome-wide genetic variants. This information in the genome 
was investigated if they reflect assumptions based on our understanding of 
evolution of these breeds throughout the history.  
 
Mentioned below are the specific objectives of the thesis: 
 
Study I - III 
 To determine the genetic variants associated with IBH.  
 To determine the genetic variants associated with IBH utilizing a 
combined dataset and validating associated genetic variants.  
 To determine the genetic variants associated with IBH utilizing 
increased SNPs density in an inbred horse population.  
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Study IV 
 To investigate level of inbreeding and evolutionary history of various 
horse populations. 
 To quantify differences in the genome between these populations. 
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3 Summary of the studies 
This thesis comprises three studies (I-III) related to insect bite hypersensitivity 
(IBH), and one study related to genetic diversity and genetic differences 
between various horse populations (Study IV). The Studies I-III were 
performed to identify genetic variants (genomic regions) associated with IBH. 
Study IV was performed to understand qualitative and quantitative genetic 
relationships along with evolutionary history between various horse 
populations.  
The summary of the first three Studies I – III will be presented first which 
will be followed by summary of Study IV.  
3.1 Materials and methods (Study I-III) 
3.1.1 Composition of data 
Information on Studies I – III regarding horse breed, number of horses in 
different categories (affected, unaffected, female, male, type of genotyping 
array used etc.) are presented in Table 1.  
Study I consisted of 209 Icelandic horses. The majority (97%) of Icelandic 
horses were born in Sweden and the remaining horses were imported from 
Iceland, the Netherlands and Norway. These horses were paternal half-sibs.  
Study II consisted of 355 Icelandic horses and 280 Exmoor ponies. The 355 
Icelandic horses consisted of the 209 Icelandic horses included in study I, and 
146 Icelandic horses sampled in the Netherlands. The data consisted of 
Icelandic horses born in Sweden (57.2%), in the Netherlands (34.6%), in 
Iceland (5.6%)  or in other European countries (2.5%). 76.9% of the Icelandic 
horses were in paternal half-sib groups. The remaining Icelandic horses were 
maternal half-sibs and full-sibs. For validation purpose in the Study II, the 280 
Exmoor ponies that were also included in Study III were used.  
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Study III consisted of 280 Exmoor ponies genotyped using latest 
genotyping array. Out of 336 available Exmoor ponies, 26 ponies were 
removed due to unclear status of IBH, incomplete pedigree information (less 
than 4 generations) or not recorded as a purebred. Average relatedness was 
estimated for the remaining 310 ponies using the genetic software 
Contribution, Inbreeding, Coancestry (CFC) (Sargolzaei et al., 2006). We 
aimed for including ponies with low average relatedness to the group. 
Furthermore, 280 Exmoor ponies were selected from 310 ponies based on 
several steps of quality control to ensure gender balance (mostly females were 
removed) and good quality of DNA (blood samples from young ponies were 
given priority).  
3.1.2 Phenotype assessment 
In Study I, data collection began already in 2005. The data was collected by a 
questionnaire, that we distributed through websites, horse magazines, and the 
Icelandic horse association. Information about the horse (name, registration 
number, birth year, sex, country of origin, current location), IBH (status, 
season and age of onset of IBH, severity of IBH, affected areas on body), other 
allergies, and IBH status of the dam were collected through the questionnaire. 
The horses were classified as affected or unaffected based on the clinical 
symptoms of IBH observed and reported by the horse owners. Veterinarians 
later confirmed the symptoms while collecting blood samples. The distinct 
seasonal character of IBH facilitates diagnosis. Horses that showed seasonal 
symptoms of IBH for at least two grazing seasons were considered affected 
horses. The unaffected horses had never developed clinical symptoms of IBH 
and were at least 4 years old. The age of all horses ranged from 4 till 27.  
In study II, besides the Icelandic horses sampled in Sweden as described 
earlier, additional Icelandic horses were sampled in 2010 in the Netherlands 
through publications on various horse related websites. The unaffected and 
affected horses were matched on different characteristics such as gender, age, 
sire and coat colour. A veterinarian and a researcher visited the horse owners. 
They conducted an IBH related questionnaire to the horse owners and scored 
IBH phenotypes. The affected horses showed clinical symptoms of IBH, and 
seasonality was taken into account. To increase reliability of diagnosis of IBH, 
the following criteria were considered: the unaffected horses must had an 
exposure to Culicoides spp. and should have never developed clinical 
symptoms of IBH, the unaffected horses should be at least 4 years of age, the 
unaffected horses must have been exposed to Culicoides spp for at least a year, 
and had never showed clinical symptoms of IBH. The age of horses ranged 
from 4 till 35 years.  
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In study III, data was collected from 2008 till 2011 through an open call to 
owners via the Exmoor pony society and online postings. The questionaire 
contained information about the pony (name, gender, registration number, birth 
year, location, history of any disease), the pony’s owner (name, location), 
environmental conditions (stabling, grazing, humidity, shelter, preventive 
measures: blankets), clinical symptoms of IBH (body location of crust, 
swelling, wounds, hair loss, skin thickening; age of onset of symptoms), and 
IBH status of sire and dam. The affected ponies showed clinical symptoms of 
IBH and were categorized by their owners as mildly, moderately or severely 
affected by IBH based on clinical symptoms and preventive measures 
implemented. The unaffected ponies did not show any clinical symptoms of 
IBH. Not all answers to the questions regarding environmental conditions were 
complete. For 24 Exmoor ponies age information was not available and around 
30 unaffected Exmoor ponies out of 280 Exmoor ponies were 1 – 3 years old. 
Similar age distribution was observed in affected (mean = 10.2, median = 8) 
and unaffected group (mean = 10.9, median = 9).   
3.1.3 Genotyping  
Genome-wide evenly spaced SNPs are being increasingly utilized in 
association studies to identify SNPs close in LD with causal variants associated 
with traits of interest. To identify genetic variants, in our studies I-III we 
collected SNPs information using the most up-to-date genotyping array 
available at that time. In Study I, the first genotyping array developed for the 
horse, the Illumina Equine50KSNP BeadChip, was used to genotype 54,602 
SNPs in 209 Swedish-born Icelandic horses. In Study II, the Illumina 
Equine70KSNP BeadChip was used to genotype 65,157 SNPs in 146 Icelandic 
horses sampled in the Netherlands. In Study III, the 670K Affymetrix Axiom 
array, was used to genotype 670,796 SNPs in 280 Exmoor ponies. With the 
development of new genotyping arrays in time, we could increase the number 
of SNPs being genotyped in populations. A large number of evenly spaced 
SNPs better represents the horse genome. With increase in density of SNPs in 
the genome, there is increase in chance of high LD among SNPs. If there is 
high LD among SNPs, chances of these SNPs being in LD with causal variants 
also increases. 
3.1.4 Quality control and Population stratification analysis 
Quality control and population stratification analyses were performed using 
GenABEL package (Aulchenko et al., 2007) in the statistical software R. The 
quality control thresholds for the studies I-III are presented in Table 1. A 
stratified population can lead to false positive associations especially in case-
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control GWA studies (Balding 2006). Hence, the potential presence of 
subpopulations was investigated using post-quality control dataset (Table 1) in 
Studies I – III. Multidimensional scaling (MDS) plots were constructed to 
visualize the distribution of affected and unaffected horses. In Study I and II, 
the result from a preliminary mixed model approach with single SNPs using 
the GenABEL package in R was compared with the expected distribution of P-
values to obtain the genomic inflation factor (λ), which was used to detect if 
there was stratification. In the study III, the genomic inflation factors were 
calculated using different models. 
3.1.5 Genome-wide association study 
In studies I and II, a case-control association test was performed using the 
Bayesian variable selection method Bayes C implemented in version 4.0 of 
GenSel software available online (http://bigs.ansci.iastate.edu/). In this method, 
all SNPs were fitted simultaneously as random effects in the model with only 
few SNPs assigned to having an effect and the remaining SNPs assigned to 
having no effect. No covariates were used in the model. The prior for marker 
variance was derived from the additive genetic variance based on the 
heritability of 0.27 for IBH as a binary trait (Eriksson et al., 2008). Two 
hundred thousand Markov Chain Monte Carlo cycles were performed. On each 
cycle, 99.9% of all SNPs were assumed to have no effect in the model. The 
first 50% of the cycles were discarded as a burn-in period and estimates from 
every 100th cycle were saved.  
The horse genome build (EquCab 2.0) was divided into 2,371 non-
overlapping 1-mb windows in the study I, and 2,373 non-overlapping 1-mb 
windows in the study II. The windows explaining more than the expected 
percentage (for example in the study I: 100%/2,371 = 0.042%) of genetic 
variance were considered to be non-randomly associated with IBH. Within 
these 1-mb windows, the SNP with highest model frequency was considered to 
be associated with IBH. Model frequency of the SNP refers to the proportion 
of the post burn-in cycles that included the SNP in the model. 
In the study III, the association tests were performed using the GenABEL 
package (Aulchenko et al., 2007) in the statistical software R. Case-control 
association tests were performed using structured association approach and a 
principal component analysis (PCA) method. Association tests were also 
performed using the severity of IBH. A mixed-model structured association 
approach and PCA method was applied. A single SNP was fitted in all the 
models without any covariates. 
 33 
3.1.6 Validation study 
In study II, the SNPs with highest model frequency were selected for 
validation. The selected SNPs, located on chromosome 1, 3 and X, were used 
for validation in 280 Exmoor ponies. The genotype information for the selected 
SNPs was obtained via Taqman SNP Genotyping Assay. The association 
between IBH in Exmoor ponies and the selected SNPs were investigated using 
a chi square test with 1 degree of freedom in the online statistical software 
(www.vassarstats.net).  
Table 1. Horse breeds, genotyping platforms, number of  horses in total and in different categories, 
number of SNPs pre and post quality control, and quality control thresholds utilized in the studies I, 
II and III 
 Study I Study II Study III 
Horse breed Icelandic horses Icelandic horses         
Exmoor ponies 
Exmoor ponies 
Genotyping platform Illumina Equine 
SNP50 Genotyping 
BeadChip 
Icelandic horses: 
Illumina SNP50 and 
Illumina SNP70 
Genotyping 
BeadChip 
670K Axiom Equine 
Genotyping Array 
Number of SNPs 54,602 45,986 670,796 
    
Number of horses 209 355 280 
Affected  104 177 110 
Unaffected 105 178 170 
Number of sires and 
dams 
42 sires and 207 
dams 
136 sires and 333 
dams 
107 sires and 226 
dams 
Gender    
Female (Affected; 
Unaffected) 
104 (51; 53) 198 (102; 96) 186 (68; 118) 
Male (Affected; 
Unaffected) 
105 (53; 52) 157 (75; 82) 94 (42; 52) 
Quality control thresholds   
Genotyping frequency 
per horse for inclusion 
>= 95% >= 95% > 90% 
Genotyping frequency 
per SNP for inclusion 
< 95% < 95% < 90% 
Minor allele frequency 
per SNP for exclusion 
< 5% < 5% < 0.05% 
    
Post quality control    
Number of horses 209 355 268 
Number of SNPs 38,486 33,523 452,457 
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3.2 Main findings 
3.2.1 Population stratification: 
In Study I two separate populations were observed in MDS plot (Figure 3). The 
value of the genomic inflation factor was 0.81 indicating no stratification for 
IBH status however. In Study II, two separate populations were observed in 
MDS plot (Figure 4). The value of the genomic inflation factor was 0.92 
indicating no stratification. In Study III, separate populations were not 
observed in MDS plot (Figure 5). The genomic inflation factor values differed 
for four different models applied in the study. The values ranged from 1.02 
(mixed-model structured association approach) to 1.36 (structured association 
approach). 
 
Figure 3. Multidimensional scaling plot for 209 Icelandic horses in Study I. Principal component 
1 (PC1) explained 6.18% of the variance and Principal component 2 (PC2) explained 3.90%. 
Each dot represents an individual. 
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Figure 4. Multidimensional scaling plot for 355 Icelandic horses in Study II. Principal component 
1 (PC1) explained 3.83% of the variance and Principal component 2 (PC2) explained 2.64%. 
Each dot represents an individual. 
Figure 5. Multidimensional scaling plot for 268 Exmoor ponies in Study III. Each dot represents 
an individual. 
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3.2.2 Genome-wide association study: 
Top 10 1-mb windows explaining highest percentage of genetic variance of 
IBH, in Study I and Study II are presented in Table 2. In Study I, 29 1-mb 
windows explained ≥0.14% of the genetic variance of IBH (data not shown), 
and these windows were investigated for immunity-related genes, allergy-
related genes, and genes directly or indirectly involved in skin function. 
Immunity-related genes were observed in the genomic regions on 
chromosomes (chr) 7, 10, and 17.  
A 1-mb window at 57 mb on chr 7 contained a gene cathepsin C (CTSC). 
CTSC was located 600 kb downstream of the associated SNP BIEC2-1002972 
within this window. CTSC been shown to play a role in MHC class II antigen 
presentation in humans (Rebhan et al., 1998). 
A 1-mb window located at 35 mb on chr 10 contained the gene inhibitor of 
bruton agammaglobulinemia tyrosine kinase (IBTK) 159 kb downstream of the 
SNP BIEC2-115349 associated with IBH. IBTK regulates the activity of 
Bruton’s tyrosine kinase (BTK), which is required for B-cell development in 
humans and mice (Spatuzza et al., 2008). Progenitor B cells transform into 
mature B cells and lead to the production of different immunoglobulins: IgG, 
IgM, IgA, IgD, and IgE. B cells play a role in the adaptive immune system, and 
defects in B-cell development, selection, and function can lead to the 
development of immunodeficiency, allergies, and autoimmunity (Pieper et al., 
2013). 
A 1-mb window located at 77 mb on chr 17 contained a gene, insulin 
receptor substrate 2 (IRS2) located 105 kb upstream of the associated SNP 
BIEC2-385377. IRS2 is associated with the total level of IgE in asthmatic 
patients and plays a role in the modulation of antibody levels (Acevedo et al., 
2009). In humans, IRS2 interacts with the immune response interleukin 9 (IL-9) 
signaling pathway and is one of the related super-pathways (Rebhan et al., 
1998). In mice IL-9 increases production of IgE (Petit-Frere et al., 1993) and 
showed that IgE mediates type I hypersensitivity reactions.  
In Study II, for Icelandic horses, top ten 1-mb non-randomly associated 
windows (Table 2) were investigated for immunity-related genes, allergy-
related genes, and genes directly or indirectly involved in skin function. 
Immunity-related genes were observed close to the associated windows on chr 
1 and chr 15.  
On chr 1, RAS guanyl releasing protein 1 (calcium and DAG20 regulated) 
(RASGRP1) was located upstream [149,706,774-149,775,059 bp] of the 
associated 1-mb window 152 mb. RASGRP1 plays an essential role in IgE 
mediated allergic response in mice. In humans, RASGRP1 regulates T and B 
cell development and is associated with the autoimmune disease systemic 
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lupus erythematosus (GeneCards). In horses, RASGRP1 gene has 64 
orthologues (Ensembl (Equ Cab 2)) and is 92.7% similar to human RASGRP1 
implying similar role of RASGRP1 in horses and humans. Any disruption in the 
regulation of T and B cell development may influence the production of IgE 
and likely 1 the development of IBH, as IBH is an IgE mediated 
hypersensitivity reaction (Klumplerova et al., 2013).   
On chr 15, a gene Interleukin 1 receptor antagonist (IL1RN) located on chr 
15 [16,048,492-16,054,21210 bp], ~4 mb upstream of the window at 19 mb in 
the study I. IL1RN was one of the candidate genes investigated for an 
association with IBH susceptibility in Old Kladruby horses (Vychodilova et 
al., 2013). One can speculate that associated region could be a regulatory 
region for IL1RN.  
In the Exmoor ponies, two SNPs on chr 1 were associated with IBH. SNP 
BIEC2_65455 (OR = 0.65, 95% confidence interval: 0.46 – 0.92) was 
successfully genotyped in 277 ponies. The risk allele frequency for this SNP 
was 0.50 in the unaffected group and 0.60 in the affected group. SNP 
BIEC2_65299 (OR = 1.52, 95% confidence interval: 1.08 – 2.15) was 
successfully genotyped in 278 ponies. The risk allele frequency was 0.49 in the 
unaffected group and 0.60 in the affected group. 
In Study III, no single SNP demonstrated genome-wide significance in any 
of the four GWA analyses performed. However, two regions on chr 8 were 
studied closer. First region chr.8: 70,269,986– 71,065,803, contained a SNP 
AX-104130346 that got the lowest p-value (Punadjusted) in 3 out of the 4 analyses 
and bordered on genome-wide significance (Pgenome-wide) in two analyses. The 
risk allele frequency was 0.46 in the unaffected group and 0.54 in affected 
group. This SNP was located in DCC netrin 1 receptor gene (DCC). In 
humans, DCC has been associated with apoptosis and functions as a tumor 
suppressor (GeneCards). Second region chr 8: 78,377,554– 78,880,555, 
consisted of 4 SNPs. Within this region a SNP AX-104330407 was focused on 
because this SNP resulted in the lowest p-value in one of the GWA analyses 
and was in the top 10 results of the other three GWA analyses. Immunity 
related gene TNFRSF11A was observed closest to the SNP AX-104330407. 
TNFRSF11A plays a role in autoinflammatory disorder in humans (Jeru et al., 
2014). TNFRSF11A might also play a role in hypersensitive reactions because 
autoinflammatory disorder and allergic disorders are caused by dysfunction of 
the immune system.  
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Table 2. Top 10, 1-mb non-overlapping windows in Study I and Study II ranked according to 
explained highest percentage of genetic variance of IBH, along with risk allele frequency of SNPs 
associated with IBH within a window 
 1-mb windows explaining highest genetic 
variance (%) 
 Associated SNP within 1-mb window 
Chr1 mb2 No. SNP 
in window 
Gen. 
var 
(%)3 
p>AVG4  SNP name MF5 Position of 
SNP (bp) 
Risk allele 
frequency 
Unaff6 Aff7 
Study I 32 73a 20 0.51 0.04  BIEC2-1132313 0.009 73,129,947 0.34 0.66 
32 74b 16 0.36 0.04  BIEC2-1133113 0.004 74,332,689 0.45 0.55 
17 77c 17 0.34 0.03  BIEC2-385377 0.016 77,343,575 0.43 0.57 
18 26c 15 0.34 0.03  BIEC2-409581 0.011 26,766,516 0.43 0.57 
10 41  17 0.33 0.04  BIEC2-119028 0.009 41,699,776 0.35 0.65 
32 76 17 0.27 0.02  BIEC2-1133893 0.009 76,174,026 0.40 0.60 
10 35 10 0.24 0.02  BIEC2-115349 0.007 35,942,977 0.42 0.58 
10 49 14 0.23 0.02  BIEC2-121644 0.004 49,192,501 0.47 0.53 
32 78 15 0.23 0.03  BIEC2-1134793 0.006 78,794,348 0.42 0.58 
5 71 17 0.22 0.03  BIEC2-917852 0.005 71,366,629 0.45 0.55 
Study II 32 82a 12 1.71 0.10  BIEC2_1138724 0.085 82,842,940 0.42 0.58 
1 153b 14 1.02 0.07  BIEC2_65455 0.054 153,075,829 0.46 0.54 
22 25c 12 0.62 0.05  BIEC2_589497 0.038 25,515,664 0.46 0.54 
3 35 17 0.54 0.07  BIEC2_776764 0.017 35,408,432 0.44 0.56 
18 32 21 0.52 0.05  BIEC2_410288 0.012 32,615,336 0.43 0.57 
32 76 21 0.45 0.05  BIEC2_1133893 0.017 76,174,026 0.41 0.59 
4 100 18 0.44 0.05  BIEC2_878810 0.031 100,879,322 0.44 0.56 
11 0 13 0.43 0.05  BIEC2_133565 0.015 300,347 0.39 0.61 
1 152 19 0.42 0.05  BIEC2_65299 0.013 152,871,014 0.46 0.54 
15 19 17 0.41 0.04  BIEC2_293386 0.013 19,652,562 0.42 0.58 
 
1 Chr: Chromosome number. 
2mb: Mega base pair, 24 mb specifies a region from 24 mb to 25 mb (1-mb). 
3Gen. var (%): Percentage of genetic variance explained by the window calculated using every 100th cycle after 
burn-in cycles. 
4p>AVG: Proportion of cycles where the window explained more than the expected genetic variance 0.042%. 
5MF: Model frequency is a proportion of post burn-in cycles where the SNP included in the model had an 
effect. 
6Unaff: Unaffected group of horses 
7Aff: Affected group of horses 
a, b, c: top three windows that explained the highest, second highest and third highest percentage of the genetic 
variance. 
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3.3 Materials and methods (Study IV) 
3.3.1 Horse data and quality control 
Study IV consisted of 203 horses representing nine populations (Table 3). The 
SNPs (n = 45,986) overlapping between two genotyping platform: Illumnia® 
EquineSNP50 Genotyping BeadChip and Illumnia® EquineSNP70 Genotyping 
BeadChip were used. Quality control was performed using PLINK software 
(Purcell et al., 2007). SNPs present on the X chromosome were removed 
followed by the SNPs with a genotyping rate <90%, and a minor allele 
frequency (MAF) < 1%. Horses with genotyping rate > 90% were accepted for 
further analysis. A dataset pruned based on LD was also created apart from a 
dataset without LD based pruning.  
All analyses were performed using PLINK software (version 1.07) (Purcell 
et al., 2007) unless specified.  
3.3.2 Inbreeding coefficient 
Inbreeding coefficients were estimated to study the genetic diversity status 
within the populations. SNPs in LD can reduce the information-content of a 
dataset (Lopes et al., 2013) and may lead to a less accurate estimation of 
inbreeding coefficients. Inbreeding coefficients ( if ) were estimated using data 
obtained after LD-based SNP pruning.  
Inbreeding results in homozygosity. Hence, inbreeding coefficient was also 
determined by calculating the proportion of the autosomal genome that was 
homozygous. Runs of homozygosity (ROHs), long stretches of homozygous 
SNPs, were identified to determine the homozygous segments in the genome. 
Inbreeding coefficients ( ROHif , ) was estimated as defined by (McQuillan et 
al., 2008). 
3.3.3 Genetic relationships within and among horse populations 
The genome-wide genetic relationships within and between the 203 horses 
from nine horse populations were visualized using MDS plot. The MDS plot 
also served as a quality control, as it exposes potential breed-misclassification 
of a horse. 
To get a quantitative measure of genetic differentiation between the horse 
populations, fixation index FST was estimated in PLINK (version 1.9) (Purcell 
et al., 2007). FST values per SNP were estimated based on the method 
described by (Weir & Cockerham, 1984). FST values per SNP between two 
populations were averaged to establish the genetic differentiation between 
these populations.  
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3.3.4 Runs of homozygosity 
Runs of homozygosity (ROHs), in the genome were identified to detect 
genomic regions potentially under selection. To discover ROHs, a window of 
50 SNPs was slid across the genome, one SNP at a time. We considered 
genomic regions in more detail when an at least partially overlapping ROH 
was present in at least 25% of all horses across populations, or in at least 80% 
of the horses within a population. The genomic regions where no or hardly any 
ROH was detected were also considered in detail.  
3.4 Main Findings 
3.4.1 Estimates of Inbreeding coefficient 
In general, inbreeding in populations that allow introgression was lower 
compared to inbreeding in closed populations. The highest mean inbreeding 
coefficients were observed in the Friesian horse if  = 30.4%, ROHif ,  = 22.2%) 
and Shetland pony populations ( if  =24.0%, ROHif , =14.3%). The lowest 
mean inbreeding coefficients were observed in the KWPN sport horse ( if  =-
6.9%) and Icelandic horse ( ROHif ,  = 4.3%). Lowest inbreeding was observed 
in the KWPN sport horses as a result of introgression from other European 
warmblood populations to enhance performance traits.   
3.4.2 Genetic relationships within and among horse populations  
The quantified relationships among populations were as expected based on the 
history and classifications of the populations. The relationships quantified 
using the MDS plot (Figure 6) and FST values were similar. In MDS plot, 
warmblood populations, coldblood populations and pony- like populations 
clustered together (Figure 6). The four Dutch warmblood horse populations: 
the Gelder horses, harness horses, KWPN sport horses and Groninger horses 
showed moderate genetic differentiation (pairwise mean FST ≤ 0.07). This 
moderate differentiation between the Dutch warmblood populations confirms 
the origin of the populations. Exchange of genetic materials occurred between 
Gelder horses (light draft horse) and Groninger horses (heavy draft horse) long 
time ago to enhance each other’s trait (Hendricks, 1995). Gelder horses, 
harness horses and KWPN sport horses constitute the KWPN horse population, 
whereas Groninger horses are preserved and registered by the Groninger horse 
association as a separate warmblood population.  
The pony-like populations clustering together in the MDS plot, showed 
moderate genetic differentiation (FST = 0.078). The pony-like populations, 
Shetland ponies and Icelandic horses, likely shared ancestors more recently 
than with other populations (Hendricks, 1995). 
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Estimated genetic differentiation was greatest for the Friesian horse 
population (FST ranged from 0.13 to 0.17).  
3.4.3 Runs of homozygosity 
Genomic regions with SNPs present in a homozygous segment in many 
horses might indicate signatures of selection, or, conserved regions throughout 
evolutionary history. Across populations, ≥25% of all horses studied had SNPs 
in a homozygous segment located on chr 7, chr 10 and chr 11. Within 
populations, genomic regions potentially indicating signatures of selection 
were located on chr 1 for Shetland ponies and on chr 8 and chr 24 for Friesian 
horses. Many genes were located within the genomic regions identified across 
and within populations. 
Genomic regions that contained very few or no SNPs that were present in a 
homozygous segment were identified on chr 5, chr 8, chr 18 and chr 20. The 
genomic region on chr 5 (14.1-15.0Mb) contained the gene, LXN (OMIM: 
609305). The region surrounding LXN did not contain SNPs that were present 
in a homozygous segment. The change in expression of LXN decreased the 
number of hematopoietic stem cells in laboratory mice (Liang et al., 2007). 
The hematopoietic stem cells are considered a model for endogenous stem cell 
populations. Natural variation in the size of endogenous stem cell populations 
is important for several biological processes like homeostatic tissue 
regeneration and potentially organismal longevity. Based on these findings, 
LXN seems to be a potential candidate gene for which, from an evolutionary 
perspective, variation is preserved. The genomic region on chr 8 (0.1-0.7 mb) 
contained a gene MED15 (OMIM: 607372), essential for signal transduction of 
for instance TFGB and Activin (Yang et al., 2006). Additional research is 
required to understand if these genes are conserved based on evolutionary 
perspective. 
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Table 3. Data description including the number of horses (N), country of origin, type of studbook, 
and a description of the 9 populations sampled in the Netherlands in Study IV 
Population N Country of origin Type Studbook Description 
Belgian draft 
horse 
23 Belgium Coldblood Closed Heavy draft horse 
Friesian horse 20 the Netherlands Coldblood Closed Harness and riding 
horse 
Gelder horse 20 the Netherlands  Warmblood Open, introgression of 
warmblood horses 
Light draft and riding 
horse 
Groninger 
horse 
20 the Netherlands Warmblood Closed Heavy draft and riding 
horse 
Harness horse 20 the Netherlands Warmblood Open, introgression of Hackney 
and American Saddlebred 
horses 
Harness horse 
Icelandic horse 39 Iceland Coldblood Closed Gaited, riding horse 
KWPN sport 
horse 
18 the Netherlands Warmblood Open, introgression of 
Thoroughbred and warmblood 
sport horses 
Sport horse, jumping or 
dressage 
Lipizzaner 
horse 
23 Lipica, modern-
day Slovenia 
Warmblood Closed, use of several sire and 
dam lines 
Riding horse, Spanish 
riding school 
Shetland pony 20 Shetland Isles, 
Scotland 
Coldblood Closed, four categories based on 
withers height 
Harness and riding pony 
 
 
Figure 6. Multidimensional scaling plot of 203 horses from 9 populations in Study IV. The X-axis 
represents the first component (C1) and Y-axis the second component (C2). 
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4 General discussion 
In this thesis, we utilized genetic variation in two horse populations to 
understand the genetics behind IBH susceptibility. We also utilized the genetic 
variation within and between horse populations to understand their genetic 
diversity status, genomic relationships, and evolutionary history of the 
populations.  
The first section of this discussion will focus on genotypic, phenotypic and 
environmental aspects of IBH which is required to better estimate the genetic 
variation of IBH susceptibility. This section will discuss findings regarding 
IBH susceptibility in Studies I-III, and discuss alternatives to better capture the 
genetic variants associated with IBH.  
The second section of this discussion will address how knowledge of 
genetic relationships between various horse populations might contribute to 
understand IBH susceptibility across populations. 
4.1 Genotype 
To better understand the genetic variation of IBH susceptibility we analyzed 
different datasets that included different number of samples and different 
number of SNPs. We will address the findings regarding IBH from the Studies 
I-III and discuss consequences of increasing sample size, number of SNPs on 
the outcome of the different studies.  
4.1.1 IBH: complex allergic disorder 
IBH is considered a polygenic disorder, which is also influenced by 
environmental factors. This concept has been supported by candidate gene 
studies and by GWA studies (Table 4). Studies I-III performed in this thesis 
also support this concept. In Study I and II, we estimated an effect of multiple 
windows defined along the genome, on IBH susceptibility. In Study I, 29 non-
overlapping windows, 1-mb in length, explained 0.14 – 0.51% of the genetic 
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variance (data not shown). Similarly in Study II, 30 non-overlapping windows 
explained 0.19 – 1.71% of the genetic variance of IBH (data not shown). The 
study by Schurink et al. (2012) on IBH susceptibility also showed 20 windows 
explaining 0.14 – 0.62% of the genetic variance of IBH in Shetland pony mares 
and 0.14 – 0.65% of the genetic variance in Icelandic horses. The identified 
windows in the Study I and II influenced IBH with small effects. By using a 
similar method of identifying genomic regions, in layer chickens, Wolc et al. 
(2012) estimated the influence of multiple 1-mb non-overlapping windows on 
the complex traits, egg uniformity and egg weight. Top 10 1-mb windows 
associated with egg weight (eggs laid between 26 and 28 weeks of age), 
explained 1.1 – 28.0% of the genetic variance (Wolc et al., 2012). With large 
number of samples (29,000 individuals) genomic regions for the complex traits 
were identified (Wolc et al., 2012). Also for IBH, a larger number of horses 
would increase the chances of finding regions with effects on IBH.  
To compare the effect sizes of the different associated SNPs with IBH 
within the Studies I, II and III, and also with previous studies (Table 4) we 
calculated odds ratio (OR) for the SNPs (Table 5). In general, OR represents 
the odds that an outcome will occur given a particular exposure, compared to 
the odds of the outcome occurring in the absence of that exposure (Szumilas, 
2010). OR also provides a measure of association (maybe not statistically 
significant) for example between a SNP (or allele of SNP) and trait of interest 
where OR = 1 indicates lack of association; OR > 1 and OR < 1 corresponds 
with increasing and decreasing odds respectively, with presence of that allele 
of SNP. In case of association studies, OR is an exponential function of the 
allele substitution effect (eb1, where b1 is an allele substitution effect) 
associated with a one-unit increase in the exposure (Szumilas, 2010). In this 
thesis, OR was determined as eb1. In Study I and II, we estimated OR based on 
an allele substitution effects of a minor allele of the top SNPs within the 10 
windows that had highest association with IBH (Table 4). In the studies I and 
II, the effects of the SNPs (allele substitution effects) were estimated based on 
study by Kizilkaya et al. (2010) implemented in GenSel software. In Study III, 
we used allele substitution effects for a minor allele of the top 10 SNPs that 
were obtained using mixed model structured association (Table 5) because this 
model gave the lowest value for genomic inflation factor in this study.  
The OR values of the SNPs in Study III (Table 5) ranged from 1.6 to 8.4, 
and were similar to OR values in the study by Schurink et al. (2013a). In our 
case, OR of 1.6 denotes that a heterozygote horse carrying a minor allele (risk 
allele) will have probability of developing IBH by 1.6 times compared to a 
horse homozygous for the major allele (protective allele). However, these OR 
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values obtained in the Study III by fitting a single SNP in a model might be 
overestimated because of small number of horses in the study (Xu, 2003).     
The OR values in the Studies I and II (Table 5) were lower compared to in 
Study III (Table 5) and other studies. This might be because allele substitution 
effects of the SNPs associated with IBH in Study I and II are partial effects of 
the SNPs (Garrick & Fernando, 2013). In the Study I and II, multiple SNPs 
were simultaneously fitted in the model. When multiple SNPs fitted 
simultaneously are in high LD the partial effects of the SNPs tend to get 
smaller (Garrick & Fernando, 2013). Multiple SNPs being in high LD is likely 
present in the studies I and II, resulting in small effect sizes for the associated 
SNPs compared to the effects as estimated in the study III.  
Table 4. Odds Ratio of associated genetic variants with IBH susceptibility in previous candidate 
gene studies and GWA studies  
Reference 
 
Study type Breeds Na Phenotype Genetic variants 
used 
Associated genetic 
variants 
ORb 
Andersson et 
al. 2012 
Candidate 
gene study 
Icelandic 
horse 
187 Clinical 
symptoms 
6 Microsatellites 
markers on MHC 
region; Exon2 
sequence from 
Eqca-DRA gene 
and Eqca-DRB3 
gene on MHC 
class II region 
 COR112 
(microsatellite); 
Eqca-DRB3  
4.19; 
3.60 
Andersson et 
al. 2012 
Candidate 
gene study 
Exmoor 
pony 
240 Clinical 
symptoms 
6 Microsatellites 
markers on MHC 
region; Exon2 
sequence from 
Eqca-DRA gene 
and Eqca-DRB3 
gene on MHC 
class II region 
COR112 1.48 
Klumplerova 
et al. 2012 
Candidate 
gene study 
Icelandic 
horse 
89 Clinical 
symptoms 
5 Microsatellite 
markers on MHC 
region; Exon2 
sequence from 
Eqca-DRA gene on 
MHC class II 
region 
 DRA gene 0.25 
20 SNPs in 17 
candidate allergy-
related genes 
Combined 
genotypes: CD14, 
IL23R, TSLP and 
TGFB3 
3.76-
5.16 
Vychodilova Candidate Kladruby 61 Clinical 40 SNPs in 29 
candidate genes 
Genotypes 
containing 2 to 5 
 0.06 -
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Reference 
 
Study type Breeds Na Phenotype Genetic variants 
used 
Associated genetic 
variants 
ORb 
et al. 2012 gene study horse mares symptoms (function in 
immune response 
and allergy); MHC 
region: Exon 2 
sequence of Eqca-
DRA gene and 
Eqca-DQA gene 
genes: IFNG, 
TGFB1, JAK2, 
TSLP and IVL 
12.00  
Vychodilova 
et al. 2012 
Candidate 
gene study 
Kladruby 
horse 
58 
mares 
IgE level: 
binary and 
continuous 
40 SNPs in 29 
candidate genes 
(function in 
immune response 
and allergy); MHC 
region: Exon 2 
sequence of Eqca-
DRA gene and 
Eqca-DQA gene 
Binary: IGHE, 
ELA-DRA, and 
IL10/b 
0.02 - 
13.62 
Continous: IGHE, 
FCER1A, IL4, 
IL4R, IL10, IL1RA, 
and JAK2 
Vychodilova 
et al. 2012 
Candidate 
gene study 
Kladruby 
horse 
30 
mares 
Gene 
expression 
in skin 
biopsies and 
peripheral 
blood 
leukocytes 
SNPs located on 
genes: IFNG, 
TGFB1, JAK2, 
TSLP and IVL 
IFNG and TGFB1   
Schurink et 
al. 2012 
Genome-
wide 
association 
study 
Icelandic 
horse 
146 Clinical 
symptoms 
65,175 SNPs 
(Illumina 
EquineSNP70 
Genotyping 
BeadChip) 
20 1-mb windows 
on 9 chromosomes 
explaining >0.14% 
of genetic variance 
of IBH: 1, 3, 4, 5, 
6, 7, 9, 11, 15, 18, 
19, 20, 23, and X 
  
Schurink et 
al. 2012 
Genome-
wide 
association 
study 
Shetland 
pony 
200 Clinical 
symptoms 
65,175 SNPs 
(Illumina 
EquineSNP70 
Genotyping 
BeadChip) 
20 1-mb windows 
on 14 
chromosomes 
explaining >0.14% 
of genetic variance 
of IBH: 3, 7, 8, 11, 
17, 20, 23, 27, and 
28 
  
Schurink et 
al. 2013 
Genome-
wide 
association 
study 
Shetland 
pony 
180 Clinical 
symptoms 
54,602 SNPs 
(Illumina 
EquineSNP50 
Genotyping 
BeadChip) 
24 SNPs on 12 
chromosomes: 1, 
3, 4, 6, 7, 8, 9, 11, 
17, 20, 27, 30, and 
X 
 1.94 - 
5.95 
aN: Number of horses; bOR: Odds Ratio 
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Table 5. Odds ratio for top 10 SNPs for Study I- III 
Chromosome SNP name SNP position Allele substitution effect Odds Ratio 
Study I 
5 BIEC2-917852 71,366,629 -0.001 0.999 
10 BIEC2-119028 41,699,776 0.002 1.002 
10 BIEC2-115349 35,942,977 -0.001 0.999 
10 BIEC2-121644 49,192,501 -0.001 0.999 
17 BIEC2-385377 77,343,575 -0.004 0.996 
18 BIEC2-409581 26,766,516 -0.003 0.997 
32 BIEC2-1132313 73,129,947 0.002 1.002 
32 BIEC2-1133113 74,332,689 -0.001 0.999 
32 BIEC2-1133893 76,174,026 0.002 1.002 
32 BIEC2-1134793 78,794,348 -0.001 0.999 
Study II 
1 BIEC2_65299 152,871,014 -0.003 0.997 
1 BIEC2_65455 153,075,829 -0.016 0.984 
3 BIEC2_776764 35,408,432 -0.004 0.996 
4 BIEC2_878810 100,879,322 -0.008 0.992 
11 BIEC2_133565 300,347 0.003 1.003 
15 BIEC2_293386 19,652,562 0.003 1.003 
18 BIEC2_410288 32,615,336 0.003 1.003 
22 BIEC2_589497 25,515,664 -0.010 0.990 
32 BIEC2_1138724 82,842,940 -0.021 0.979 
32 BIEC2_1133893 76,174,026 0.003 1.003 
Study III 
2 AX-103372605 116,550,518 2.134 8.445 
4 AX-103676516 16,228,799 0.874 2.395 
6 AX-102955701 55,403,540 1.652 5.217 
7 AX-103802842 36,418,118 1.779 5.924 
8 AX-104843731 62,711,228 1.332 3.788 
8 AX-104130346 71,065,803 0.517 1.677 
9 AX-104273278 9,674,307 2.006 7.434 
16 AX-104129425 79,101,000 1.502 4.490 
20 AX-103533051 29,990,169 1.679 5.362 
26 AX-104585909 14,984,244 1.843 6.319 
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4.1.2 Increased sample size and number of genetic variants 
Effect sizes of the genetic variants are likely underestimated due to incomplete 
LD between the genetic variants and causal variants. However, adding samples 
in the dataset might also lead to stratified population and one should be 
cautious while performing such procedure. To increase sample size in Study II, 
we combined data from 209 Icelandic horses sampled in Sweden and 146 
Icelandic horses sampled in the Netherlands. Two populations were genotyped 
using different genotyping platforms (Table 1). The minor allele frequencies of 
overlapped SNPs between two genotyping platforms were investigated in these 
two Icelandic horse populations. The correlation of 91% between minor allele 
frequencies of the SNPs indicated no stratification in the combined data. 
By increasing sample size from 209 horses (Study I) to 355 horses (Study 
II), we observed increment in the percentage of the genetic variance explained 
by non-randomly associated windows with IBH. The top 10 windows non-
randomly associated with IBH in Study I explained 3.07% of the genetic 
variance and in Study II explained 6.56% of the genetic variance of IBH. We 
compared total number of windows explaining ≥ 0.14% of the genetic variance 
of IBH between the Study I (29 1-mb windows) and the Study II (73 1-mb 
windows). We observed an increase in the percentage of the genetic variance 
explained by 1-mb window on chr X (82 mb, 76 mb, 4 mb) and on chr 9 (50 
mb) in the Study II compared to the Study I, at the range 1.49% to 0.03%. In 
Study II, 146 Icelandic horses were added to form a combined data. The 146 
additional Icelandic horses in Study II had previously been studied for IBH 
susceptibility (Schurink et al., 2012) by using similar approach as in Study II. 
Hence, we compared non-randomly associated windows obtained from a 
combined data in the Study II with the top 20 1-mb windows presented in the 
study by Schurink et al. (2012). The percentage of the genetic variance 
explained by five 1-mb windows on chr 1 (7 mb), chr 3 (35mb), chr 7 (55mb), 
chr 15 (19mb) and chr 18 (32mb) in the Study II compared to study by 
Schurink et al. (2012), increased at the range 0.34% to 0.08%.  
In Study I -III, we used the latest equine genotyping array available at that 
time (Table 1). In Study III, borderline association of SNPs located at chr 8 
with IBH susceptibility was observed. Association of chr 8 with IBH 
susceptibility has not been observed before in any previous GWA studies. This 
might be most likely due to use of less dense SNP genotyping arrays in the 
Study I and II, and previous GWA studies. In Study III, 425 SNPs covered 
genomic region 70-71 mb on chr 8, and genomic region 78 mb was covered by 
234 SNPs. While in the Studies I and II, less than 50 SNPs covered genomic 
region 70-71mb, and less than 25 SNPs covered genomic region 78 mb on chr 
8 (Figure 7). The percentage of the genetic variance explained by 1-mb 
 49 
windows on chr 8 [71 mb, 72 mb  and 78 mb] in the Studies I and II was ≤ 
0.07%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3 Heritability  
In the Study III, the heritability in Exmoor ponies was estimated to be 39.70% 
using IBH severity as a trait in a mixed model structured association approach. 
This estimated heritability is comparable to pedigree based heritability estimate 
(33%) of IBH (severity as trait) for Swedish-born Icelandic horse population 
(Eriksson et al., 2008). Estimated heritability in the Study III could be inflated 
because environmental factors were not included in the model as answers 
obtained from participants via questionnaire, regarding the environmental 
factors, were not consistent in the Study III.  
The genomic heritability, proportion of total variance explained by all 
SNPs, estimated in the Study I (11.4%) and the Study II (12.7%) was lower 
compared to pedigree based heritability of 27%, which was used to calculate 
prior for the genetic variance of IBH in Studies I and II. The heritability for 
IBH as a binary trait was estimated to be 27% (Eriksson et al., 2008). Such 
scenario, referred to as missing heritability, has been encountered in GWA 
studies of complex traits for example human height, for disease such as 
schizophrenia, and others as reviewed in Maher (2008). In the study by 
Schurink et al. (2012), all SNPs explained 13% of variance as compared to 
Figure 7. SNPs density at 78mb on chromosome 8 in 50K and 670K SNP chip. A line represents 
one SNP.  
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24% obtained by using pedigree information in Dutch Shetland pony mares. 
Estimates of heritability using genome-wide SNPs was 30% lower compared to 
the pedigree-based heritability for egg weight (Wolc et al., 2012). Use of 
higher value of the probability, π = 99.5% was suggested as one of the reason 
for low heritability estimate (Wolc et al., 2012). The probability “π,” indicates 
the percentage of SNPs assigned to having no effect on the trait, on each 
iteration. In the Studies I and II, we assigned 99.9% of the SNPs to have no 
effect on the trait IBH which could be one reason for low heritability estimates. 
Use of paternal half-sibs to design a matched case-control structure in the 
Study I might have influenced estimate of heritability.  
To fill the gap of missing heritability, several methods has been proposed 
(Maher, 2008) such as increasing SNPs density, increasing sample size, and 
investigating alternative forms of genetic variants. In case of IBH, increment in 
number of Icelandic horse population gave similar values for SNP based 
heritability estimates in the Studies I and II. It might be case that rare variants 
are involved in influencing IBH susceptibility. To capture such rare variants 
more horses are required (Robinson et al., 2014). Using dense SNPs in Exmoor 
pony population we estimated higher SNP based heritability as mentioned 
before. To better capture the genetic variation alternative forms of genetic 
variants could also be investigated. These genetic variants might influence IBH 
susceptibility in horses, however following section will be focused on CNVs 
and epigenetics. The potential of CNVs and epigenetics to better identify 
genetic variants in IBH and explain larger portion of genetic variance will be 
discussed. 
The heritability estimates of allergies reported in human are higher 
compared to IBH heritability estimated (as binary trait) in different horse 
breeds, 16% to 27% (Schurink et al., 2011; Schurink et al., 2009; Eriksson et 
al., 2008). Heritability estimates in humans utilized Monozygotic (MZ) and 
Dizygotic (DZ) twin pairs where only three essential statistics (MZ 
resemblance, DZ resemblance and total phenotypic variation) can be 
determined. However, many other genetic and non-genetic causal components 
might be contributing to the total phenotypic variation in the twin study 
designs. If phenotypic variation is not partitioned properly into causal sources, 
confounding will lead to bias in the estimate of heritability. For full sibs or DZ 
twins it is difficult to separate the dominance component from the common 
environmental component that might lead to upward bias in heritability 
estimates (Visscher et al., 2008).  
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4.1.4 Copy number variants and Epigenetics 
Copy number variants 
Copy number variants (CNVs) are segments of DNA ~1kb in length or larger 
in size present at different copy number in comparison with reference genome 
(Feuk et al., 2006). Fifteen percentage of heritability estimate of schizophrenia 
was explained by 4 CNVs (Nagao, 2015). Use of CNVs for heritability 
estimation of IBH in horses is limited.   
Analysis of CNVs related to allergy is highly relevant because studies on 
CNVs have revealed that the majority of genes containing CNVs are involved 
in immune response in humans (Redon et al., 2006), in cattle (Bickhart et al., 
2012), and in horses (Ghosh et al., 2014; Metzger et al., 2013). Changes 
occurring in CNVs may cause changes in expression of the genes containing 
CNVs by either dysregulating RNA levels (increasing or decreasing), or by 
modifying the structure of the gene.  
In horses, studies regarding association between IBH and CNVs are limited. 
However in humans, CNVs have been associated to allergic disorder such as 
atopic dermatitis (AD) (Brown et al., 2012). AD in humans and IBH in horses 
have shown similar features (Schaffartzik et al., 2012). Similar to IBH, AD is 
chronically relapsing, non-contagious, pruritic, IgE mediated hypersensitivity 
reaction, and share similar histopathological (microscopic examination of 
tissues) findings with IBH. In humans, CNVs within Filaggrin (FLG) gene was 
observed to be associated with AD susceptibility (Brown et al., 2012). FLG 
gene alleles contained 10, 11 or 12 tandem repeats of ~972 bp in 3rd exon of 
FLG. Individuals with different alleles expressed different amount of FLG in 
the epidermis. Each addition of copy number of FLG reduced OR of AD 
susceptibility by a factor of 0.88 (CI 0.78 – 0.98) which suggest CNVs in FLG 
as a dose-dependent contribution to AD susceptibility. In horses also, role of 
FLG in IBH susceptibility was investigated. Expression of FLG in skin 
biopsies between IBH affected and unaffected Belgian warmblood horses did 
not show any significant difference. However, incorrect annotation of FLG 
complementary DNA (cDNA) sequence in the horse genome was suggested 
(Peeters, 2013). Therefore, a further investigation of CNVs in FLG in horses 
and association of FLG with IBH susceptibility seems to be required. 
Direct investigation of CNVs is suggested as only biallelic CNVs (deletions 
and duplications) can be tagged by SNPs (Redon et al., 2006). It is challenging 
to tag complex CNVs or multiallelic CNVs (Beckmann et al., 2007) using 
SNPs. Hence, investigation of CNVs might contribute to identify genetic 
variants influencing IBH susceptibility, and also contribute to explain missing 
heritability.  
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Epigenetics  
Epigenetic variations occur due to environmental factors and lead to changes in 
gene expressions without altering nucleotides on the sequences. These 
variations occur through DNA methylation (DNAm), histone modification and 
micro RNAs (Baye et al., 2010).  
In humans, epigenetic modifications have been associated with 
susceptibility to different allergies in candidate gene approach and genome-
wide approach. Associations of the epigenetic modifications have been 
investigated in a specific region of a candidate gene, forkhead transcription 
factor (FOXP3) gene (Hinz et al., 2012). Children with low number of 
demethylated Treg cells (low FOXP3 gene expression) showed a higher risk of 
developing AD (OR: 1.55, 95% CI = 1.00-2.41) and food allergies (OR: 1.5, 
95% CI = 1.06-2.25) in the first year of life. Increase in susceptibility towards 
allergy in children with low number of demethylated Treg cells suggests a role 
of DNAm patterns in FOXP3 gene in susceptibility towards allergy. In horses 
also effector T cells are suppressed in a similar way by Treg cells as in humans 
(Meulenbroeks, 2015a). Any changes in the stability of Treg cells may lead to 
abnormal immune response resulting in allergic response in horses. Hence, 
investigation of DNAm patterns of Treg cells regarding IBH is also of interest 
in horses. In horses, increased level of DNAm in PAX5 gene in bone marrow, 
further supported by decreased mRNA expression of PAX5 gene was observed 
in common variable immune deficient (CVID) horses (Tallmadge et al., 2015). 
However, epigenetic modifications have not been analyzed in relation to IBH 
susceptibility in horses. With significance of epigenetic modifications to 
maintain balance in different levels of the immune system (for example T-cell 
differentiation), epigenetics is an important aspect that should be considered. 
Such a study should be considered to understand biological mechanisms 
underlying IBH susceptibility such that specific, efficient therapy can be 
introduced to reduce the prevalence of IBH and thus contributing to horse-
welfare. 
4.1.5 Study design 
An ideal design of a GWA study depends on the genetic architecture of the 
trait of interest. In Studies I, II and III, we performed GWA analysis to find 
genomic regions associated with IBH, a common complex trait. In Studies I 
and II, a case-control design was used. In Study III, GWA analyses were 
performed using IBH as binary trait as well as a continuous trait, taking 
severity of the clinical symptoms into account. A case-control design is 
sensitive to population stratification, which might lead to false positive results 
if not taken into account. In the studies I, II and III, we visualized if any 
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subpopulations were present via MDS plot. Although two subpopulations were 
present in the MDS plot in the study I (Figure 3) and the study II (Figure 4), 
the genomic inflation factor was less than 1, which confirmed no effect of 
stratification. In the studies I and II, we fitted multiple SNPs simultaneously in 
a model. In such case, some of the SNPs will simultaneously account for 
known or unknown population structure (Fernando & Garrick, 2013).  
In the Study III, although the MDS plot (Figure 5) did not show a structure 
with subpopulations in Exmoor pony population, the values for genomic 
inflation factor obtained after fitting models such as structured association and 
principal component analysis-based method were greater than 1 showing effect 
of stratification. The significance values for associated SNPs were then 
corrected using inflation factor obtained in respective models. Among the 
investigated models to investigate association, only mixed model structure 
association showed a genomic inflation factor close to one in the Study III. 
A case-control design has also been used in the candidate gene association 
studies (Table 4). The candidate gene studies using case-control designs might 
also suffer from population stratification (Cardon & Palmer, 2003), that can 
increase the risk of inaccurate estimation of genetic variation if not taken into 
account. Also, the candidate gene studies will exclude vast information of the 
genome that may lead to inaccurate estimation of genetic variation. A matched 
case-control design was used in the Studies I – III. To correct for the 
population stratification due to pedigree, paternal-half sibs were used in the 
Studies I and II, and full-sibs were used in Study III (Schurink et al., 2012). 
We observed association of multiple SNPs, with small effects, with IBH 
susceptibility in the studies I, II, and III. In Studies I and II, we observed that 
top SNPs associated with IBH had small effects. We increased SNPs density in 
the Study III, none of the SNPs was significantly associated with IBH 
susceptibility after correcting for multiple testing. This hints that to tag genetic 
variants for a complex trait such as IBH we need much larger sample size 
compared to sample size used in the studies I-III. In GWA studies for complex 
traits, use of large sample size and dense SNP for mapping traits in domestic 
species has been suggested (Goddard & Hayes, 2009). However, data 
collection from large number of horses is challenging compared to other 
domestic species as cattle, pigs because horses are owned by private owners 
and are distributed in different geographical areas. It is also challenging to 
apply a strict identical protocol to diagnose IBH and gather consistent 
information about environmental factors in large number of horses gathered 
from different areas. In such case, large number of horses for IBH can be 
gathered by forming large collaborative groups of researchers with the goals of 
sharing material, data, and standardizing diagnosis and experimental methods 
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for IBH. The genetic diversity study performed in 814 horses from 30 different 
breeds (correcting for breeds in case of IBH association analysis) could be one 
example of a large international collaboration (Petersen et al., 2013) in a field 
of horse genetics. As an alternative to collecting large samples for GWA 
studies we can also look towards including other types of study designs such as 
family-based designs along with GWA studies as a next step.   
Family-based design 
A robust way to identify and characterize variants influencing disease 
susceptibility including IBH could be to use a test that combine both linkage 
and association mapping, transmission disequilibrium test (TDT) (Ott et al., 
2011; Spielman et al., 1993). TDT estimates frequency of allele transmission 
from parents to offspring on heterozygous loci. This design is not susceptible 
to population stratification as allele or genotype frequencies are not considered 
(Ott et al., 2011). Usually TDT is performed to identify linkage after 
association has been established between a genetic variant and trait of interest, 
and act like a validating step for association studies (Spielman et al., 1993). In 
humans, linkage and GWA studies have identified variants associated with 
diseases such as Crohn’s disease as reviewed in Ott et al. (2011) and AD 
(Enomoto et al., 2007). TDT has been used to confirm association results when 
many associations has been identified as reviewed in Ott et al. (2011). In the 
current case of IBH, where multiple genetic variants has been identified, with 
significant or suggestive associations, in different studies, performing TDT is 
an interesting option. 
4.1.6 Major histocompatibility complex 
The MHC region has been significantly associated with IBH susceptibility in 
candidate gene studies (Klumplerova et al., 2013; Andersson et al., 2012b) but 
causal variant has not been identified yet. GWA studies for IBH susceptibility 
can help to confirm previously associated genomic region and also to identify 
novel genomic regions associated with IBH susceptibility. In the Studies I and 
II, approximately five 1-Mb windows covered the MHC region and 
surroundings on chr 20. In the Study I, each of the five windows explained 
0.04-0.05% of the total genetic variance of IBH susceptibility. One of the five 
1-Mb windows at a genomic region 33mb on chr 20 in Study II explained 
0.15% of the genetic variance compared to 0.05% for the same corresponding 
window in Study I. This is most likely due to the increment in number of 
horses in Study II (355 horses) compared to in Study I (209 horses). A window 
at 35mb on chr 20 explained highest percentage (0.62%) of the genetic 
variance for IBH susceptibility in Dutch Shetland pony mares (Schurink et al., 
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2012). A window at 30mb on chr 20 explained 0.17% of the genetic variance 
in Icelandic horses (Schurink et al., 2012). 
Previous GWA studies including the Studies I and II used SNP chip with 
less dense SNPs. We investigated the number of SNPs around MHC region and 
surroundings. The number of SNPs spanning MHC region and surroundings 
(~30-34 Mb) was around 100 in the Studies I and II. This number increased 
considerably to more than 6.3 thousand in Study III where we used the 670K 
Genotyping Array. We also observed that SNPs in MHC region are not evenly 
distributed (Figure 8) based on the current available genetic map of MHC 
region for horse genome (Equcab 2.0).  
In Study III, a SNP 33.32 mb downstream the DRB gene in the MHC region 
was observed within top 10 SNPs associated with IBH susceptibility. After 
correcting for multiple tests none of the SNPs showed genome-wide 
significance in the Study III. Using large number of horses might increase the 
significance of the genetic variants.  
In humans, MHC region contains high gene density, gene duplication, 
diversity and has low recombination events (Traherne, 2008; Gustafson et al., 
2003). The genes in MHC region are suggested to be extremely polymorphic 
for example in humans, more than 2,000 alleles are observed in the DRB loci 
of MHC class II region (Immuno Polymorphism Database). In humans, the 
structural and copy number variants are regarded as an important source of 
diversity in MHC region (Ghosh et al., 2014; Traherne, 2008). Also, other 
sources of variation such as epistasis, epigenetics might play role in diversity 
among genes on MHC region and influence disease susceptibility (Traherne, 
2008). Hence, in case of IBH susceptibility, different sources of variants 
should also be considered in addition to SNPs.  
Mapping of MHC region is still on progress. Any conclusion regarding 
analysis of the MHC region is preliminary as fine mapping and annotation 
needs to be performed to further improve the possibilities to study this region. 
Improvements might be observed via studies focused on the MHC region alone 
in horses, supplemented by work to generate third assembly of horse genome 
with improved maps and annotation of genes. The third assembly of horse 
genome will be available soon (Kalbfleisch et al., 2014). Hence, to investigate 
influence of MHC region on IBH susceptibility, sequencing MHC region might 
be a good strategy. Advancement in sequencing technologies has been 
successful to produce long reads of sequences with less error which can give 
correct map and annotation of regions with segmental duplication like MHC to 
construct fine map of regions containing segmental duplications less complex. 
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Figure 8. SNP density on MHC class II region and surroundings, from 50K SNP chip (on top) and 
670K SNP chip (on botton). A gap on 670K SNP chip is seen around 3.3 mb. 
4.2 Phenotype 
An accurate phenotyping of a trait is paramount in any studies. Accurate 
phenotyping can compensate in part for the requirement of large number of 
samples. To better estimate the genetic variations in case of IBH too, accurate 
phenotyping, which can be translated to accurate diagnosis of affected and 
unaffected horses, is of immense importance. Diagnosis of IBH in horses is a 
challenging procedure and should be performed with caution and considering 
essential criteria discussed earlier in the thesis. Here, the discussion will focus 
on other methods that can act as a supplement to the methods, to further 
improve reliability of IBH status of horses. 
4.2.1 Diagnosis of IBH 
4.2.1.1 Clinical symptoms 
The clinical symptoms of IBH include intense itching leading to scratching, 
hair loss, scaling, thickening of skin, open wounds and secondary infections 
(Schurink et al., 2011; Bjornsdottir et al., 2006). The clinical symptoms can in 
general be recognized by horse owners themselves. This enables the possibility 
to collect phenotypes on a large number of horses in a relatively easy way by 
consulting horse-owners, or inspectors. Itching might however also be caused 
by ecto-parasites such as mites or lice that can also enhance innate 
inflammatory responses, adaptive immune reactions and altered behavior 
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(Wilson, 2014), and additional information is required to exclude other causes 
of itch. This additional information can be collected through offering a 
questionnaire to owners with questions about location of the clinical symptoms 
on the horse (typically mane and tail), seasonality, and recurrence of symptoms 
in subsequent years, medical history of horse, type of preventive measures 
(stabling, rugs), and therapeutic measures against IBH. In particular the 
seasonality of IBH is a distinct characteristic of this allergic disorder, by which 
itching caused by ecto-parasites can be ruled out. 
Collection of IBH data was performed through questionnaire in various 
studies (Peeters et al., 2015; Andersson et al., 2012b; Eriksson et al., 2008), 
including the studies described in this thesis Horse owner have additional 
knowledge about the health of the horse, over a longer period of time as 
opposed to a once only observation (Peeters et al., 2015; Eriksson et al., 2008). 
Practical limitations of gathering data using a questionnaire might be that 
mainly the horse owners who have affected horses will be eager to reply such 
that the collected data does not represent the population (Schurink, 2012). Non-
responding should therefore be reduced as much as possible.  
The clinical symptoms combined with well-documented medical history of 
the horse are still considered as the golden standard for diagnosis of IBH 
(Langner et al., 2008; Baselgia et al., 2006). Including falsely diagnosed horses 
in studies will reduce the power of investigating IBH susceptibility. Therefore 
horses included in the control group should certainly be not sensitive to IBH. 
Certainty about sensitivity is absent if horses are not exposed to Culicoides or 
if use of preventive measures such as keeping horses in the stables and use of 
protective rugs is limiting exposure to Culicoides spp. Certainty about the 
chosen unaffected horses was increased in this thesis by including Icelandic 
horses in Studies I and II that were at least 4 years of age, which is beyond the 
commonly assumed age of onset for IBH of 2 to 4 years. In Study I, unaffected 
Icelandic horses had an exposure to Culicoides spp. and had never developed 
clinical symptoms. Unaffected Icelandic horses sampled in the Netherlands, in 
Study II, were at least one year at risk of developing symptoms of IBH. 
4.2.1.2 In-vivo and in-vitro diagnostic methods 
Different in-vivo and in-vitro diagnostic tests such as intradermal tests (IDT) 
(Langner et al., 2008; Fadok & Greiner, 1990), allergen-specific IgE and IgG 
enzyme-linked immunosorbent assay (ELISA) (van der Meide et al., 2014; 
Langner et al., 2008), basophil degranulation test/histamine release test (HRT) 
(Langner et al., 2008) and the cellular antigen stimulation tests/ 
sulfidoleukotriene test (Klumplerova et al., 2013; Marti et al., 1999) can 
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supplement the clinical diagnosis of IBH (Meulenbroeks, 2015a), as a more 
detailed description about the allergic reaction can be given.  
IBH affected horses showed increased IgE reactivity against allergens from 
Culicoides spp. compared to IBH unaffected horses (van der Meide et al., 
2014; Hellberg et al., 2009). Diagnostic tests for IBH do not always match 
results from clinical inspection for IBH as e.g. shown in the study by van der 
Meide et al. (2014) by using recombinant allergens. In an ELISA test, 76 to 
85% of IBH affected horses showed IgE reactivitiy towards recombinant 
allergens developed from Culicoides obsoletus complex (van der Meide et al., 
2014). The horses that did not show IgE reactivity, but had clinical symptoms 
of IBH, were likely showing symptoms from cross-reactions. Use of individual 
recombinant allergens in ELISA can distinguish genuine sensitization from 
sensitization against cross-reactive allergens (van der Meide et al., 2014). The 
horses developing genuine sensitization might have different genetic 
background compared to the horses developing cross-reactive allergens, which 
should be accounted for in genetic analyses.  
Different biological mechanisms in the horses might be acting towards 
different allergens. Hence, it is important to study a group of horses sensitized 
to allergens from the same Culicoides spp.. In the Netherlands, Culicoides 
obsoletus are found to be the major cause of IBH (Raat et al., 2008; Rijt et al., 
2008). Icelandic horses and Shetland ponies sampled in the Netherlands 
showed increased IgE reactivity towards recombinant allergens from 
Culicoides obsoletus compared to a homolog from Culicoides sonoresis (van 
der Meide et al., 2013). Hence, it is important to know which Culicoides spp. 
are causing IBH to avoid false diagnosis. Culicoides spp. causing IBH varies 
by country and region (Rijt et al., 2008). In Study I, Icelandic horses were 
sampled from five different regions in Sweden. The knowledge regarding type 
of biting midges causing IBH in Sweden is limited (Eriksson et al., 2008), and 
type of Culicoides spp might vary between regions. In Study III, most of the 
Exmoor ponies were sampled from England in the United Kingdom (UK). 
Culicoides pulicaris were potentially the cause of IBH in England (Mellor & 
McCaig, 1974). The recombinant allergens derived from Culicoides obsoletus 
complex (van der Meide et al., 2014) might not be suitable for horses sampled 
in Sweden and the UK. Diagnostic tests can help to identify the Culicoides spp. 
that is responsible for IBH in a population. Additionally, allergen specific IgE 
levels, as derived from a diagnostic test can be used as a quantitative trait 
(Vychodilova et al., 2013). The quantitative trait has a potential to improve 
reliability of individual phenotype and seems to be more suitable to perform 
GWA study (Schurink, 2012), as it allows for variation of degree of 
sensitization.  
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For diagnosis of IBH, thorough clinical examination and medical history of 
the horses as well as diagnostic tests should be included to increase reliability 
of diagnosis of IBH. The specificity and sensitivity of the type of diagnostic 
tests used in the study should also be taken into account. In a study by 
Klumplerova et al. (2013), the diagnostic tests served as a quality control and 
horses that had positive scores in diagnostic tests but had no clinical symptoms 
(sensitized horses) of IBH were removed from further analysis. The genetic 
background might be different between sensitized unaffected horses (positive 
for diagnostic tests but do not show clinical symptoms) and non-sensitized 
unaffected horses (negative for diagnostic test and do not show clinical 
symptoms). Classifying sensitized and non-sensitized unaffected horses in the 
control group in GWA studies can lead to reduction in power, assuming that 
the genetic background for IBH susceptibility differs between sensitized and 
non-sensitized unaffected horses. Hence, the horses showing both clinical 
symptoms of IBH and positive diagnostic tests can be classified as affected 
horses, and the horses with no clinical symptoms and negative diagnostic tests 
can be classified as unaffected horses. This step should be followed after 
careful evaluation of the medical history, exposure to the allergens, and other 
criteria discussed earlier. 
Because of the polygenic inheritance of IBH, the GWA studies require large 
number of affected and unaffected individuals. An ideal situation would be to 
perform diagnostic tests for all the horses in the study. However, there are 
some limitations for using diagnostic tests such as requirement of fresh blood 
samples for example in CAST, HRT (Marti et al., 1999), skilled manpower 
(for example veterinarian) for blood collection (Schurink, 2012), and 
economical issues. In addition, these diagnostic tests are invasive and requires 
ethical approval (Schurink, 2012). Performing diagnostic tests such as IDT is 
intensive than obtaining blood samples and performing ELISA tests. Also, IDT 
poses a risk of sensitizing non-sensitized horse with allergens introduced 
through the test. Using only clinical symptoms and medical history to identify 
unaffected horses for a control group poses a certain risk of selection of false 
negatives. This risk will be reduced when using diagnostic tests such as ELISA 
to confirm IBH status of horses categorized as unaffected horses from the 
clinical symptoms and medical history.  
In humans, dose-response relationship for peanut allergy was observed 
(Hourihane et al., 1997). Fourteen highly sensitive individuals, allergic to 
peanut proteins, were supplied with different dosage of peanut proteins. Few 
individuals showed allergic reactions to the lowest dosage of peanut protein 
supplied whereas other individuals did not show reactions to the highest dose 
of protein supplied. Such dose-response relationship may exist between 
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Culicoides spp. allergens and horses, and should be considered for IBH. Dose-
response relationship may influence diagnosis of IBH in unaffected horses. 
Hence, it should be made sure that unaffected horses have sufficient exposure 
to Culicoides spp. allergens. Including sufficient number of affected and 
unaffected horses from one farm/location would be an ideal scenario because 
such scenario ensures that all the horses in the study are exposed to similar 
allergens/environment for similar period of time. It is quite challenging to find 
large number of horses in one farm/location because the private owners 
residing in different locations keep horses.  
4.2.1.3 Estimated breeding values 
Determining IBH-sensitivity of a horse based on its own phenotypic expression 
might be considerably inaccurate because the IBH status is depending on 
exposure to Culicoides spp. (at a minimum density). In situations of strong 
dependence on environmental conditions, a predicted phenotype rather than the 
realized phenotype can better be used as trait under study in research and a 
prediction can be derived from the estimated breeding values (EBVs). Horses 
with highest and lowest EBVs for IBH can be selected for the association 
study, similar as was performed by Aguilar et al. (2016) in dairy cattle for 
somatic cell score. Cows with extreme high and low EBVs, that is 2 SD above 
and below the average EBVs, were selected for the association studies (Aguilar 
et al., 2016). A similar procedure can be applied for IBH in horses. The 
selected horses can be assigned based on the breeding values to the affected 
and unaffected group in association studies or alternatively the breeding values 
can directly be used as a continuous trait.  
Using EBVs directly as a phenotype in GWA studies resulted in large 
number of false positives in a study by Ekine et al. (2013). Hence de-regressed 
EBVs, also adjusted for parent average effects, can better be used for GWA 
studies. 
Accuracy of EBVs depends on heritability of trait, type and amount of 
information sources provided. For example, the accuracy of an EBV based on 
phenotypes of the sire and its progeny will be higher than when based only on 
half-sibs of the sire. When EBV is based on fewer information sources, EBVs 
tend to regress towards the mean. The accuracy of EBVs will particularly 
benefit from inclusion of (large) progeny groups. Using phenotypes derived 
from EBVs is therefore less suitable for studies on mares and on small breeds, 
because accuracies of EBVs are low due to small progeny groups. In addition, 
if there is no system to keep routine record of IBH status, it will be challenging 
to gather large amount of data. 
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4.3 Environment 
IBH is a multifactorial trait influenced by genetic and environmental factors. 
Environmental factors such as age, coat colour, body condition of horse; 
exposure of horse to allergens; preventive measures such as stabling of horses, 
and use of protective rugs have been suggested to influence development of 
IBH (Peeters et al., 2014; Schurink et al., 2013a; Olsen et al., 2011; Eriksson 
et al., 2008; Brostrom et al., 1987). The effect of sex on IBH development is 
inconclusive (Peeters et al., 2014; Eriksson et al., 2008; Brostrom et al., 1987). 
The environmental factors play an important role in development of IBH and 
thereby influence IBH prevalence. 
In the Studies I-III, the effect of sex didn’t show significance for IBH 
susceptibility for Icelandic horse populations or Exmoor pony population, and 
the sex was not included as a covariate in the analyses. Age has been found to 
be of importance for IBH, with the age of onset of IBH around 2-4 years 
(Schurink, 2012). Age was part of the selection criteria for horses to be 
included in the studies, and was not included as an effect in the models in 
Study I-II. In Study III age was unknown for a number of horses and not 
included as a covariate. 
Exposure to Culicoides spp. is crucial for development of clinical 
symptoms of IBH. The Culicoides spp. are weak fliers, and they tend to remain 
close to their breeding sites (Schurink, 2012). Considering this behavior of the 
Culicoides species it is possible that even within a region, density of Culicoides 
species can differ. As the presence of Culicoides spp vary on different 
geographical area, exposure to allergens also differ based on geographical area 
of horses. In Northen Sweden Culicoides are not densely present and to avoid 
controls that had not been exposed to allergens, only cases were selected from 
this area in Study I 
The majority of the horses (97%) in the Study I was born in Sweden. In the 
Study II, in a combined data, 57.2% of Icelandic horses were born in Sweden, 
34.6% of Icelandic horses in the Netherlands, 5.6% of Icelandic horses in 
Iceland, and remaining were born in European countries. Immune response of 
horse population might differ if the allergens differ, e.g. if different species of 
insects cause IBH. Culicoides obsoletus has been identified as a cause of IBH 
in the Netherlands (Raat et al., 2008; Rijt et al., 2008), but knowledge is 
lacking on which species are of importance for IBH in Sweden and the UK. 
Hence, studies regarding Culicoides spp causing IBH are encouraged. 
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4.4 Genetic diversity and IBH susceptibility 
Selection along with evolutionary mechanisms such as mutation, migration, 
recombination and genetic drift have led to the evolution of approximately 500 
genetically diverse horse breed types and non-breed types. Genetic diversity 
within these horse populations is of interest as the genetic diversity is essential 
to maintain survival and adaptive potential of a population (Oliehoek et al., 
2009), and to avoid inbreeding depression. Events such as population 
bottlenecks, closed breeding practices along with selection have shown to 
reduce genetic diversity. Reduced genetic diversity have been associated with 
reduced production and survival traits (Leroy et al., 2015; Thompson et al., 
2000). Reduced genetic diversity has also been associated with an increase in 
the level of infections and disease susceptibility (Cheng et al., 2012; Acevedo-
Whitehouse et al., 2003). In a population of Tasmanian devil (Sacrophilus 
harrisii), found in Tasmania Island in Australia, reduced diversity of the MHC 
genes has been suggested as a risk for development of a contagious cancer, 
devil face tumour disease (DFTD) (Siddle et al., 2007). It is suggested that 
DFTD is able to avoid the immune system due to lack of diversity in MHC 
genes.  
Reduced genetic diversity might also increase risk of allergic disorders. 
Homozygosity across the entire MHC class II region was observed to increase 
risk of IBH susceptibility (Andersson et al., 2012b). 
In study IV, genetic diversity status of nine horse populations, sampled 
from the Netherlands, was assessed using SNPs. Inbreeding coefficients (f) and 
runs of homozygosity (FROH) were investigated to get status of the genetic 
diversity of the nine horse populations. The horse populations used in the study 
IV are Belgian draft horses, Friesian horses, Icelandic horses, Shetland ponies, 
Lipizzaner horses, Groninger horses, and Warmblood population which 
include Gelder horses, Harness horses and KWPN sport horses. Many horse 
populations worldwide are affected by IBH. IBH prevalence was observed to 
be 18.2% for Dutch Friesian mare population (Schurink et al., 2011) and 8.8% 
for Dutch Shetland pony mare population (Schurink et al., 2009). The 
prevalence of IBH for Warmblood population in the Netherlands was observed 
to be lower compared to Friesian horse population, Shetland pony population 
and Icelandic horse population (van den Boom et al., 2008). Belgian 
warmblood horses showed IBH prevalence of 9.8% (Peeters et al., 2011). The 
prevalence of IBH for Swedish Icelandic horse population was observed to be 
8% (Eriksson et al., 2008). The knowledge regarding IBH prevalence in other 
breeds (Gelder horses, Groninger horses, Lipizzaner horses, Belgian draft 
horses) is limited. Heritability of IBH was estimated in Dutch Friesian 
breeding mares (0.16, SE = 0.06) (Schurink et al., 2011), Dutch Shetland 
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breeding mares (0.24, SE = 0.06) (Schurink et al., 2009), and Swedish-born 
Icelandic horses (0.33, SE < 0.2) (Eriksson et al., 2008).  
The Friesian horse population was observed to be the most inbred horse 
population (mean inbreeding coefficients: fi: 30.4%, fiROH= 22.2%) in Study IV. 
High level of inbreeding in the Friesian horse population has also been 
observed in other studies (van de Goor et al. 2011). A history of several 
population bottlenecks, a closed breeding scheme along with selection has led 
to an increase in levels of inbreeding in the Friesian horse population. The 
Friesian horse population showed the highest number of long stretches of 
ROHs (homozygous regions) suggesting recent occurrence of inbreeding in the 
population. The Friesian horse population appeared genetically different than 
other horse populations in Study IV. Hence, the genomic regions where ≥ 50% 
of the horses within the Friesian horse populations showed ROHs was selected 
for further investigation (data not shown in Study IV). The genes, present in 
the selected genomic regions, were listed using Ensembl (EquCab 2.0). The 
biological functions of known genes on the list were classified using 
PANTHER classification system (Mi et al., 2013). Using PANTHER statistical 
tool, we also performed statistical overrepresentation test for the list of genes. 
This test classifies the functions of the genes into different biological processes 
and performs binomial test on obtained processes to identify overrepresentation 
and underrepresentation of the biological processes (Mi et al., 2013). In the 
Friesian horse population we observed significant overrepresentation of the 
immune response biological process. Majority of the genes present in the 
selected genomic regions of the Friesian horse population were involved in 
immunity implying low diversity in the immunity related genes. One can  
speculate that low genetic diversity in immunity related genes in the Friesian 
horse population might have led to an increase in IBH susceptibility.  
In Study IV, KWPN sport horses showed lower level of inbreeding than 
other populations. This warmblood population had less and short ROHs. The 
diverse genome of the KWPN sport horses might be due to its open breeding 
scheme and interbreeding with other warmblood populations. Additionally, 
Thoroughbreds are introgressed in breeding of the KWPN sport horses to 
enhance performance. Introgression would result in a breaking down of ROHs, 
reducing in particular the length of ROHs and creating diversity. The 
warmblood populations were observed to have low IBH prevalence (van den 
Boom et al., 2008). One can hypothesize that a diverse genetic background in 
the warmblood population as the KWPN sport horses might be associated to 
factor to low IBH prevalence.  
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4.4.1 Genetic relationships and IBH susceptibility 
IBH is a polygenic skin allergic reaction. Different horse populations might 
share similar genetic background for IBH susceptibility. In Study IV, we 
observed moderate genetic differentiation between the Icelandic horse 
population and the Shetland pony population (FST = 0.078). Dutch Shetland 
ponies and Dutch Icelandic horses also showed IgE reactivity towards same 
recombinant allergens of Culicoides obsoletus complex (van der Meide et al., 
2014) which suggests presence of common genetic background for IBH 
susceptibility. In Study I, 1-mb window located at 66mb on chr 9 explained 
0.15% of genetic variance for IBH susceptibility in Icelandic horse 
populations. A SNP, on chr 9 significantly associated with IBH susceptibility 
in Dutch Shetland ponies (Schurink et al., 2013a), was located 452,819 bp 
upstream from the associated SNP in Study I. This suggests that some of the 
genes involved in IBH susceptibility can be found across different horse 
populations. Similarly, in Study I, a window located at 77 mb on chromosome 
17 explained 0.34% of the genetic variance for IBH susceptibility. This 
window was one of the top 3 windows associated with IBH. In Shetland pony 
mares, two 1-mb windows located at 75 and 76 mb on chr 17 explained 0.30% 
and 0.16% of the genetic variance respectively (Schurink et al., 2012). In 
Study I, a gene IRS2 functioning as immunity-related gene was identified at 77 
mb on chr 17.  The identification of these neighboring windows on 
chromosome 17 in 2 separate breeds further strengthen the potential role of 
IRS2 in IBH. With above-mentioned observations one can speculate that 
among multiple genes influencing IBH susceptibility, association of a few 
common genes can be identified in multiple populations. 
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5 Conclusions 
With references to the aims of this thesis, the specific conclusions are: 
 
Study I – III: 
I. Non-random association of multiple genetic variants in studies I – 
III showed that IBH susceptibility is influenced by many genes 
(most likely each with small effects).  
II. Increasing sample size (dataset) explained a higher proportion of 
the genetic variance of IBH.  
III. Utilizing increased number of genetic variants (density of genetic 
variants) in the genome, and inbred horse identified novel 
genomic regions. 
 
Study IV:  
I. The highest and lowest level of mean inbreeding was observed in 
Friesian horse population and KWPN sport horse population. 
II. The Friesian horse population was genetically most different than 
other horse populations. Pairwise genetic differentiation between 
Dutch warmblood populations (Gelder horse, Groninger horse and 
KWPN sport horse) was lowest compared to other pairs. 
III. Potential regions of selection within populations were observed on 
chromosomes 1, 8 and 24; across populations were observed on 
chromosomes 7, 10 and 11.  
IV. The results in this study reflected expected knowledge based on 
the evolutionary history of the studied horse populations. 
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6   Sammanfattning 
Genetisk variation som bidrar till den fenotypiska variationen användes i denna 
avhandling för att förstå den genetiska bakgrunden till en komplex egenskap 
IBH, och för att förstå den genetiska mångfalden och relationer mellan olika 
hästpopulationer. 
IBH är den vanligaste allergiska hudsjukdomen hos hästar som orsakas av 
bett av knott, främst Culicoidesarter. Det påverkar olika hästraser i världen. 
Utan effektiv behandling så försämrar IBH hästars hälsa och orsakar 
ekonomiska förluster. I denna avhandling använde vi SNP-markörer spridda 
över hela genomet för att identifiera områden som bidrar till genetisk variation 
för IBH-känslighet. Vi undersökte också inverkan av ökat antal hästar och täta 
SNP på identifiering av genomiska regioner som är associerade till IBH-
känslighet. Flera regioner med små effekter observerades i studie I-III. 
Intressanta regioner i islandshästpopulationen, i studierna I och II, 
observerades på kromosomerna 1, 7, 10, 15 och 17. Den procentuella andelen 
av den genetiska variansen som kan förklaras av tio regioner ökade från 3.07% 
(studie II) till 6.56% (studie II). Nya regioner identifierades när antalet 
islandshästar ökades i studie II. Användning av täta SNP i 
exmoorponnypopulationen ledde till att vi identifierade nya genomiska 
regioner associerade till IBH-känslighet på kromosom 8 men de låg på gränsen 
till att ha betydelse. 
I studie IV visade det sig att förkunskaper om den evolutionära historien 
hos hästpopulationer matchade de erhållna resultaten från undersökningen av 
genetiska relationer inom populationer av holländskt varmblod (parvis medel 
FST ≤ 0.070), och inom ponnyliknande populationer (parvis medel FST ≤ 
0.078). Hästpopulationer med liknande genetisk bakgrund kan dela liknande 
genetiska komponenter för IBH-känslighet. Populationen av Frieserhäst hade 
lägst variation (medelvärde inavelskoefficienterna: fi = 30.4%, fiROH = 22,2%) i 
studie IV och var genetiskt distinkta (FST till andra populationer varierade från 
0.13 till 0.17). Detta kan vara ett resultat av en historia med flera 
 68 
flaskhalseffekter och urval i en sluten population. Låg variation i 
immunitetsrelaterade gener observerades i Frieserhästpopulationen och skulle 
ha kunnat leda till ökad förekomst av IBH. På liknande sätt kan låg känslighet 
för IBH i den varmblodiga populationen KWPN sporthäst bero på hög genetisk 
variation (= -6.9%). Hög genetisk variation i KWPN sporthäst kan vara ett 
resultat av ett öppet avelssystem och korsning med andra 
varmblodspopulationer. 
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7    Samenvatting 
In dit proefschrift is de genetische achtergrond van het complexe kenmerk 
Staart- en maneneczeem (SME) bij paarden bestudeerd, alsmede de genetische 
diversiteit bij en verwantschap tussen paardenrassen.  
SME bij paarden is een allergische huidaandoening, die wordt veroorzaakt 
door beten van knutten (Culicoides). SME komt wereldwijd voor bij meerdere 
paardenrassen. Er bestaat geen effectieve behandeling tegen de aandoening en 
de aandoening is zeer belastend voor de gezondheid en welzijn van paarden. 
Bovendien leidt de aandoening tot waardevermindering van het paard. 
In dit proefschrift hebben we gebruik gemaakt genomewide SNPs om 
genoomregio's te identificeren die bijdragen aan de genetische variatie van 
SME-gevoeligheid. We onderzochten tevens het effect van verhoging van het 
aantal paarden en van SNP-dichtheid op de identificatie van betrokken 
genomische regio's.  
In de studies I-III werden meerdere regio’s gevonden met kleine effecten op 
SME-gevoeligheid. Voor IJslandse paarden, zoals geanalyseerd in studies I en 
II werden betrokken regio’s gevonden op de chromosomen 1, 7, 10, 15 en 17. 
Het percentage van de genetische variantie verklaard door de top tien windows 
steeg van 3.07% (Studie I) tot 6.56% (Studie II). Het groter aantal onderzochte 
IJslandse paarden in Studie II resulteerde in de identificatie van meer 
genomische regio’s die betrokken zijn bij SME-gevoeligheid. In studie III werd 
een high density SNPs in de analyse van Exmoor ponies gebruikt en werden 
nieuwe genomische regio's, op chromosoom 8 geïdentificeerd, alhoewel de 
significantie beperkt was. 
De resultaten van onderzoek IV ondersteunen de vanuit de historie 
veronderstelde genetische relaties binnen de Nederlandse warmbloed 
populaties (paarsgewijs gemiddelde FST ≤ 0.070), en binnen de pony-achtige 
populaties (paarsgewijs gemiddelde FST ≤ 0.078). Paardenpopulaties met 
dezelfde genetische achtergrond kunnen daarmee ook dezelfde genetische 
componenten voor SME-gevoeligheid delen. Het Friese Paard had de laagste 
diversiteit (gemiddelde inteeltcoëfficiënten: fi: 30.4%, fiROH = 22.2%) in Study 
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IV en was genetisch het meest verschillend van de andere populaties (FST 
varieerde 0.13-0.17). Dit kan een gevolg zijn van een geschiedenis met 
meerdere genetische bottlenecks en van selectie binnen een gesloten 
fokprogramma. Lage diversiteit in immuun-gerelateerde genen, zoals 
waargenomen in het Friese Paard, zou mogelijk hebben geleid tot een grotere 
prevalentie van SME. De vermeende lage prevalentie van SME in 
warmbloedpaarden zou het gevolg kunnen zijn van de hoge genetische 
diversiteit (= -6.9%). Hoge genetische diversiteit in de KWPN-sportpaard kan 
het gevolg zijn van een open fokkerij en kruisen met andere warmbloed 
populaties. 
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understanding you has made me understand myself better. Thanks for your 
support during tough times and teaching me to express myself in a healthy 
way. 
I would also like to thank all PhD students and staff in Animal Breeding 
and Genomics Centre, WU. Dear friends at wageningen Amabel, Coralia, 
Claudia, Mathijs, Zih-Hua, and Pamela, your company made my stay 
memorable. I didn’t know what to expect on my first arrival to Wageningen 
but it became smooth ride with you guys around. 
Last but not the least, my family back at home, Maa and Dad, without your 
guidance, love and support I don’t think I will be who I am. Thanks  
    
    
 Merina Shrestha 
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Training and Education                
 
                                                            
 
 
 
 
The Basic Package (8 ECTS) Year 
Welcome to EGS-ABG 2012 
Fall Research school “Animal Breeding and Society” EGS-ABG 2013 
Research Ethics (POG0054) 2014 
Fall Research School "Animal breeding and society Sustainability concept in 
animal breeding" EGS-ABG 
2015 
  
Scientific exposure (10.4 ECTS)  
International conferences (4.8 ECTS)  
10th Dorothy Russel Havemeyer Horse Genome Workshop, Azores, Portugal 2013 
EAAP-European association of animal production, Nantes, France 2013 
The Biology of Genomes, New York, USA 2014 
11th Dorothy Russel Havemeyer Horse Genome Workshop, Hanover, Germany 2015 
Plant and Animal Genome (PAG) Conference XXIV, San Diego, USA 2016 
  
Seminars and workshop (0.6 ECTS)  
One-year seminar at SLU, Uppsala, Sweden 2014 
Half-time seminar at SLU, Uppsala, Sweden 2015 
  
Presentations (5 ECTS)  
Poster Presentation in 10th Havemayer Conference, Azores, Portugal 2013 
Oral Presentation in EAAP, Nantes, France 2013 
Poster Presentation in The Biology of Genomes, New York, USA 2014 
Poster Presentation in 11th Havemayer Conference, Hanover, Germany 2015 
Poster Presentation in PAG Conference XXIV, San Diego, USA 2016 
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In-Depth Studies (22 ECTS)  
Disciplinary and interdisciplinary courses (22 ECTS)  
Domestic Animal Genetic Resources, Uppsala, Sweden 2012 
Statistical methods in Animal Breeding, Uppsala, Sweden 2012 
Basic Perl Programming for the Biological Sciences, Uppsala, Sweden 2012 
Modern Statistics for the Life Sciences (ABG-30806), Wageningen, The 
Netherlands 
2013 
Statistical Methods in Genetic Mapping- R based course, Uppsala, Sweden 2013 
Introduction to Genome Browsers, Stockholm, Sweden 2014 
Linear Models in Animal Breeding (NOVA course), Lofoten, Norway 2015 
  
Professional Skills Support Courses (13.5 ECTS)  
Introduction to SAS software for statistical analysis (SLU-P0044), Uppsala, 
Sweden 
2012 
Seminar series at SLU, Uppsala, Sweden 2012-2016 
How to write and publish a scientific paper (PVG0027), Uppsala, Sweden 2014 
Genetic analysis using ASReml4.0, Wageningen, The Netherlands 2014 
Introduction to Bioinformatics using Next Generation Sequencing data, Uppsala, 
Sweden 
2014 
  
Didactic Skills Training (7.2 ECTS)  
Lecture  
Lectures on course VM0048 (Basic Biomedicine- “Biomedicinsk Baskurs”) 2012-2013 
Lab supervisions and group discussions on “Genome Analysis” course  2013 
  
Supervising projects  
Supervising 2 short projects, Uppsala, Sweden 2013- 2014 
Supervising 1 MSc thesis 2015 
  
Total 61.1 ECTS 
 
